var title_f40_24_41344="Proximal tubule endosomes";
var content_f40_24_41344=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F62203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F62203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 571px\">",
"   <div class=\"ttl\">",
"    CI endosomes and proximal tubule cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 551px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endosomes formed from the apical surface of the proximal tubular cell bring in filtered proteins that are subsequently degraded. This process involves acidification of the endosomal lumen by the proton-ATPase. The chloride channel allows chloride to enter the vesicle to neutralize the charge generated by the proton pump, and this promotes maximal acidification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: George AL. Proc Natl Acad Sci USA 1998; 95:7843. Copyright &copy; 1998. National Academy of Sciences, USA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41344=[""].join("\n");
var outline_f40_24_41344=null;
var title_f40_24_41345="Acetabular transverse and posterior wall fractures";
var content_f40_24_41345=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acetabular transverse and posterior wall fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 407px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) The appearance on the anteroposterior&nbsp;view is similar to that of&nbsp;a pure transverse fracture with disruption of five of the six radiograph landmarks; only the radiographic U (which maintains its normal relationship to the ilioischial line) remains intact. The posterior wall fragment is seen as an oblique cortical line overlying the intact roof (arrowhead).",
"    <br>",
"     (B) The obturator oblique shows the transverse fracture, the subluxation of the femoral head with the ischiopubic fragment, as well as the posterior wall fragment. It is easy to see on this view how the femoral head may abrade against the fracture edge while the hip is subluxated.",
"     <br>",
"      (C) The iliac oblique view highlights the fracture line exiting the greater sciatic notch as well as the posterior wall fragment superimposed on the roof of the acetabulum (black arrow).",
"      <br>",
"       (D) This computed tomography section shows the posterior wall fracture (white arrow) with a column fracture line typical of a transverse fracture (black arrowheads).",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Originally published in: Moed BR, Reilly MC. Lower extremity: Acetabulum fractures. In: Rockwood and Green's Fractures in Adults, 7th ed, Bucholz RW, Court-Brown CM, Heckman JD, Tornetta P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Reproduced with permission. Copyright &copy; Berton R. Moed, MD.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41345=[""].join("\n");
var outline_f40_24_41345=null;
var title_f40_24_41346="Bicuspid aortic valve short axis echocardiogram 2";
var content_f40_24_41346=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/71102/biav2sax_conv.mp4?title=Bicuspid+aortic+valve+short+axis+echocardiogram+2\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bicuspid aortic valve short axis echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 467px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Short axis view of a 2-D echocardiogram shows a bicuspid aortic valve with two leaflets that move normally.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41346=[""].join("\n");
var outline_f40_24_41346=null;
var title_f40_24_41347="Carboprost tromethamine: Patient drug information";
var content_f40_24_41347=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Carboprost tromethamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/29/20948?source=see_link\">",
"     see \"Carboprost tromethamine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F146277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Hemabate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F146278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Hemabate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat bleeding that happens after a birth or an abortion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691645",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop bleeding from bladder irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to carboprost tromethamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703801",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have pelvic inflammatory disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697168",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have anemia, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11310 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-B6AD6E7C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41347=[""].join("\n");
var outline_f40_24_41347=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146277\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146278\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014611\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014610\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014614\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014615\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014617\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014613\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014618\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014619\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/29/20948?source=related_link\">",
"      Carboprost tromethamine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_24_41348="Vulvar cancer 4";
var content_f40_24_41348=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 501px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Exophytic vulvar carcinoma involving posterior fourchette.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scott, JR, Gibbs, RS. Danforth's Obstetrics and Gynecology, Ninth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41348=[""].join("\n");
var outline_f40_24_41348=null;
var title_f40_24_41349="Guaifenesin, pseudoephedrine, and codeine: Drug information";
var content_f40_24_41349=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Guaifenesin, pseudoephedrine, and codeine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/34/18981?source=see_link\">",
"    see \"Guaifenesin, pseudoephedrine, and codeine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F14854549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Warns of Codeine Use in Children After Tonsillectomy and/or Adenoidectomy",
"     </span>",
"     <span class=\"collapsible-date\">",
"      August 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA has issued a Drug Safety Communication after reviewing reports of children who developed serious adverse effects, including death, after receiving codeine in the usual dosage range for pain relief following tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome. Three deaths occurred in children that had evidence of a genetic variation (&ldquo;ultrarapid metabolizers&rdquo;) which results in faster and more complete conversion of codeine to morphine, possibly leading to overdose or death. The estimated incidence of this genetic variation is ~1-7 per 100 people, but may be higher in some ethnic groups.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Healthcare professionals should be aware of the risks associated with the administration of codeine or codeine-containing drugs in children after tonsillectomy and/or adenoidectomy for obstructive sleep apnea and should use the lowest effective dose for the least amount of time on an as-needed basis. Parents and caregivers who observe signs of overdose in a child such as unusual sleepiness, confusion, or difficult or noisy breathing should stop codeine administration and seek medical attention immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#",
"       </a>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cheratussin&reg; DAC;",
"     </li>",
"     <li>",
"      Mytussin&reg; DAC;",
"     </li>",
"     <li>",
"      Tricode&reg; GF",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Benylin&reg; 3.3 mg-D-E;",
"     </li>",
"     <li>",
"      Calmylin with Codeine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F178023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antitussive/Decongestant/Expectorant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F178013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Products listed in dosage forms may contain differing amounts of active ingredients; however, the dosing volume and frequency are the same.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Expectorant/decongestant/cough suppressant:",
"     </b>",
"     Oral: 10 mL every 4 hours (maximum: 40 mL/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F178019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Products listed in dosage forms may contain differing amounts of active ingredients; however, the dosing volume and frequency are the same.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Expectorant/decongestant/cough suppressant:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6-12 years: 5 mL every 4 hours (maximum: 20 mL/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F178014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral: Guaifenesin 100 mg, pseudoephedrine hydrochloride 30 mg, and codeine phosphate 10 mg per 5 mL (473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cheratussin&reg; DAC: Guaifenesin 100 mg, pseudoephedrine 30 mg and codeine phosphate 10 mg per 5 mL (473 mL) [sugar free; contains ethanol 2.1% v/v, sodium benzoate; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mytussin&reg; DAC: Guaifenesin 100 mg, pseudoephedrine hydrochloride 30 mg, and codeine phosphate 10 mg per 5 mL (118 mL, 473 mL) [sugar free; contains ethanol 1.7%; strawberry-raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tricode&reg; GF: Guaifenesin 200 mg, pseudoephedrine hydrochloride 30 mg, and codeine phosphate 8 mg per 5 mL (473 mL) [ethanol free, dye free, gluten free, sugar free; contains propylene glycol; grape flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F177990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F178025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-V",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F178003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Temporarily relieves nasal congestion and controls cough associated with upper respiratory infections and related conditions (common cold, sinusitis, bronchitis, influenza)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F178021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3362494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to guaifenesin, pseudoephedrine, codeine, or any component of the formulation; use with or within 14 days of MAO inhibitor therapy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3362495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenanthrene hypersensitivity: Use with caution in patients with hypersensitivity reactions to other phenanthrene derivative opioid agonists (hydrocodone, hydromorphone, levorphanol, oxycodone, oxymorphone).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension and ischemic heart disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure/glaucoma: Use with caution in patients with increased intraocular pressure or glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pulmonary disease or decrease ventilatory function; dose-related respiratory depression occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ulcerative colitis: Use with caution in patients with chronic ulcerative colitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy of this combination have not been established in children &lt;2 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cough: Appropriate use: Underlying cause of cough should be determined prior to prescribing. Use caution with persistent cough or chronic cough (as with smoking, asthma, chronic bronchitis, emphysema) or cough accompanied by excessive phlegm. Re-evaluate if cough persists &gt;7 days.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299428\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F177996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Aluminum Hydroxide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Alpha-/Beta-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bromocriptine: Alpha-/Beta-Agonists may enhance the adverse/toxic effect of Bromocriptine. Including increased blood pressure, ventricular arrhythmias, and seizure.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: May decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha-/Beta-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha-/Beta-Agonists (Indirect-Acting) may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha-/Beta-Agonists (Indirect-Acting).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the tachycardic effect of Alpha-/Beta-Agonists. Serotonin/Norepinephrine Reuptake Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatostatin Analogs: May decrease the metabolism of Codeine. The formation of two major codeine metabolites (morphine and norcodeine) may be impaired by somatostatin analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Spironolactone: May diminish the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F177997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3362492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with this combination. See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3362493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F178006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Lortuss EX Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     22.5-10-100 mg/5 mL (473 mL): $83.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Tricode GF Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-8-200 mg/5 mL (473 mL): $94.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Zodryl DEC 25 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-1-20 mg/mL (118 mL): $35.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Zodryl DEC 30 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4.286-1-20 mg/mL (118 mL): $35.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Zodryl DEC 35 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.75-1-20 mg/mL (118 mL): $35.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Zodryl DEC 40 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.333-1-20 mg/mL (118 mL): $35.00",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F178007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Benylin 3.3 mg-D-E (CA);",
"     </li>",
"     <li>",
"      Calmylin with Codeine (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F178005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8751 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-9F69235DB9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41349=[""].join("\n");
var outline_f40_24_41349=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14854549\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178009\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178010\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178023\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178013\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178019\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178014\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178001\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F177990\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178025\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178003\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178021\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3362494\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3362495\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299428\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F177996\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F177997\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3362492\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3362493\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178006\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178007\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178005\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8751\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8751|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/34/18981?source=related_link\">",
"      Guaifenesin, pseudoephedrine, and codeine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_24_41350="Skin and eye manifestations of inflammatory bowel disease";
var content_f40_24_41350=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Skin and eye manifestations of inflammatory bowel disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Mark A Peppercorn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41350/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/24/41350/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of conditions arise outside of the gastrointestinal tract that are associated with inflammatory bowel disease (IBD); these are termed extraintestinal manifestations of IBD (",
"    <a class=\"graphic graphic_table graphicRef81867 \" href=\"mobipreview.htm?27/32/28173\">",
"     table 1",
"    </a>",
"    ). Some of these entities are associated more with Crohn's disease than ulcerative colitis, including oral lesions, clubbing, gallstones, pancreatitis, and renal and urologic conditions such as calcium oxalate stones, cystitis secondary to enterovesical fistulae, and amyloidosis. Other extraintestinal findings, including skin and eye disorders, are seen with equal frequency in both Crohn's disease and ulcerative colitis and may dominate the clinical presentation.",
"   </p>",
"   <p>",
"    The exact prevalence of extraintestinal findings in patients with IBD has not been extensively studied, although they appear to be common. A study using administrative health data at a tertiary center in Canada estimated that a total of 6 percent of patients with IBD had one of six major extraintestinal diseases that were studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/1\">",
"     1",
"    </a>",
"    ]. A study from the Mayo Clinic found that 40 percent of IBD patient had one or more extraintestinal manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of extraintestinal manifestations is incompletely understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SKIN MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of skin disorders may be seen in association with inflammatory bowel disease (IBD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Erythema nodosum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythema nodosum is the cutaneous disorder most frequently seen with ulcerative colitis and Crohn's disease, occurring in 4 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/3\">",
"     3",
"    </a>",
"    ]. It typically appears as raised, tender, red or violet subcutaneous nodules that are 1 to 5 cm in diameter (",
"    <a class=\"graphic graphic_picture graphicRef80056 \" href=\"mobipreview.htm?8/46/8943\">",
"     picture 1",
"    </a>",
"    ). The nodules are most commonly located on the extensor surfaces of the extremities, particularly over the anterior tibial area. Biopsy of these lesions shows focal panniculitis, although the diagnosis is most often clinical; biopsy is rarely required. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13130?source=see_link\">",
"     \"Erythema nodosum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The appearance of erythema nodosum usually parallels intestinal disease activity, and treatment directed at the underlying bowel disease usually results in elimination of the lesions. However, skin nodules occasionally precede any bowel symptoms, or occur during quiescent phases of IBD; in these settings, therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    may be required. The usual starting dose is 40",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    A response is typically seen within one week; the prednisone can then be tapered over the ensuing three to four weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pyoderma gangrenosum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proportion of patients with inflammatory bowel disease who develop pyoderma gangrenosum appears to be small [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In a cohort study of 2402 patients with inflammatory bowel disease, pyoderma gangrenosum was detected in only 0.75 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/3\">",
"     3",
"    </a>",
"    ]. Despite its relatively infrequent occurrence, it often has more serious consequences than erythema nodosum such as persistence of the lesions and local discomfort even with appropriate therapy.",
"   </p>",
"   <p>",
"    The lesions initially may appear as single or multiple erythematous papules or pustules that are often preceded by trauma to the skin (",
"    <a class=\"graphic graphic_picture graphicRef53733 \" href=\"mobipreview.htm?38/17/39187\">",
"     picture 2",
"    </a>",
"    ). They occur most commonly on the legs, but can develop in any area of the body, including the abdominal wall adjacent to the stoma after colectomy as well as in other surgical scars or areas of trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/5\">",
"     5",
"    </a>",
"    ]. Subsequent necrosis of the dermis leads to the development of deep ulcerations that contain purulent material which is usually sterile on culture (",
"    <a class=\"graphic graphic_picture graphicRef52528 \" href=\"mobipreview.htm?7/47/7920\">",
"     picture 3",
"    </a>",
"    ). Biopsy reveals nonspecific findings consistent with a sterile abscess (",
"    <a class=\"graphic graphic_picture graphicRef59489 \" href=\"mobipreview.htm?26/55/27508\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Pyoderma gangrenosum lesions parallel IBD activity in only about 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/6\">",
"     6",
"    </a>",
"    ]. Therapy directed at the underlying IBD usually results in healing in these instances, although treatment often needs to include a several week course of high dose glucocorticoids. The treatment of pyoderma gangrenosum is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/61/10202?source=see_link&amp;anchor=H1178500#H1178500\">",
"     \"Pyoderma gangrenosum: Treatment and prognosis\", section on 'Approach to treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Miscellaneous skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many other skin lesions may be seen in patients with IBD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sweet syndrome is an acute, inflammatory dermatitis characterized by raised, tender nodules distributed on the face, arm and trunk and sometimes associated with fever and constitutional symptoms (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30393?source=see_link\">",
"       \"Neutrophilic dermatoses\"",
"      </a>",
"      ). A number of cases have been associated with either ulcerative colitis or Crohn's disease. Biopsy of the lesion reveals an intense neutrophilic infiltrate without evidence of vasculitis. The lesions of Sweet syndrome usually respond quickly to oral glucocorticoids [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Necrotizing cutaneous vasculitis is rarely associated with IBD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/8\">",
"       8",
"      </a>",
"      ]. It is a serious complication which can progress to peripheral gangrene. Aggressive management with high dose steroids and possible colectomy is indicated.",
"     </li>",
"     <li>",
"      Psoriasis occurs more commonly in patients with Crohn's disease than in the general population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. In one study, for example, psoriasis was present in 13 of 136 patients (9.6 percent) with Crohn's disease compared to 3 of 136 (2.2 percent) controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/10\">",
"       10",
"      </a>",
"      ]. It was also more common in relatives of patients with Crohn's disease compared to relatives of controls (10 and 2.9 percent, respectively). Patients with psoriasis complicated by psoriatic arthritis commonly have microscopic inflammation in the colon even if they do not have bowel symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anti-TNF therapy has been associated with the development of eczematous and psoriasiform lesions. As a general rule, these can be treated with topical therapy and only rarely require discontinuation of treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Epidermolysis bullosa acquisita has rarely been associated with Crohn's disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lesions termed metastatic Crohn's disease have been described, consisting of ulcerating nodules that show noncaseating granulomas on biopsy. These lesions can occur anywhere on the body; they have been most frequently described on the anterior abdominal wall in the submammary area, and on the arms and legs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. They respond well to systemic steroids. There is also a report of metastatic Crohn's disease responding to treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among patients with IBD, the use of thiopurines has been associated with an increased risk of nonmelanoma skin cancer (NMSC). In one study, for example, the hazard ratio for squamous cell carcinoma was 5.4 (95% CI 2.0-15.6) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. The risk of NMSC was increased with both ongoing and past exposure to thiopurines (ongoing exposure HR 5.9, 95% CI 2.1-16.4; past exposure HR 3.9, 95% CI 1.3-12.1) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/19\">",
"       19",
"      </a>",
"      ]. In another observational study, the use of anti-TNF medication, but not thiopurine use, was associated with an increased risk of melanoma (OR 1.88, 95% CI 1.1-3.3) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EYE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episcleritis and uveitis are the most frequent eye manifestations of inflammatory bowel disease",
"    <span class=\"nowrap\">",
"     (IBD).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Episcleritis/scleritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episcleritis/scleritis",
"    occurs in 2 to 5 percent of patients with IBD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/20\">",
"     20",
"    </a>",
"    ]. Affected patients may be asymptomatic or complain of burning and itching. Injection of the ciliary vessels and inflammation of the episcleral tissues are the prominent features on physical examination; episcleral nodules may also be present (",
"    <a class=\"graphic graphic_picture graphicRef76962 graphicRef67740 \" href=\"mobipreview.htm?1/11/1203\">",
"     picture 5A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/80?source=see_link\">",
"     \"Episcleritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/32/22023?source=see_link\">",
"     \"Clinical manifestations and diagnosis of scleritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therapy directed at the underlying IBD and topical glucocorticoids&nbsp;for episcleritis or systemic therapy for scleritis is almost always successful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/80?source=see_link\">",
"     \"Episcleritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11511?source=see_link\">",
"     \"Treatment of scleritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Uveitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uveitis is less common than episcleritis, occurring in 0.5 to 3 percent of patients with IBD. However, its consequences often are more severe. The uveitis is frequently bilateral, posterior to the lens, insidious in onset, chronic in duration, and four times more common in females than males [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/21\">",
"     21",
"    </a>",
"    ]. Approximately 75 percent of patients have an associated arthritis that may be axial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peripheral and may therefore simulate a spondyloarthropathy. Distinguishing initially between these disorders may be difficult since approximately one-half of patients with IBD have the HLA-B27 phenotype and, in 10 of 17 patients in one series, the uveitis preceded signs of inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/16/23817?source=see_link\">",
"     \"Uveitis: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Affected patients present with eye pain, blurred vision, photophobia, and headaches. A slit-lamp examination reveals inflammation in the anterior chamber with perilimbic edema, cells, and protein. Corneal clouding and conjunctival injection may also be seen (",
"    <a class=\"graphic graphic_picture graphicRef75384 \" href=\"mobipreview.htm?33/3/33854\">",
"     picture 6",
"    </a>",
"    ). An acute episode may be followed by iris atrophy, lens deposits, and synechiae.",
"   </p>",
"   <p>",
"    The course of the uveitis may not parallel the activity of the IBD. Prompt diagnosis and therapy with topical or systemic steroids is required. A topical mydriatic such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/31/33264?source=see_link\">",
"     scopolamine",
"    </a>",
"    (0.25 percent) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/34/24100?source=see_link\">",
"     cyclopentolate",
"    </a>",
"    (1 percent) may help relieve spasm.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     Infliximab",
"    </a>",
"    can be effective in patients with refractory disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/22\">",
"     22",
"    </a>",
"    ].Secondary glaucoma and rarely blindness may occur if correct management is delayed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/10/10407?source=see_link\">",
"     \"Uveitis: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Miscellaneous eye conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other eye conditions may be seen more rarely in patients with IBD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The development of cataracts is a common concern in patients with IBD who are chronically treated with glucocorticoids. Regular ophthalmologic examinations should be considered in these patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=see_link\">",
"       \"Major side effects of systemic glucocorticoids\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Retinal vascular disease with central vein occlusion, and retinal vasculitis involving the retinal arteries have rarely been reported in Crohn's disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Subepithelial keratopathy, peripheral corneal ulcers, and corneal infiltrates have been described in several patients with Crohn's disease and ulcerative colitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Central serous chorioretinopathy with bullous retinal detachment has been reported in one patient with ulcerative colitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41350/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/24/20866?source=see_link\">",
"       \"Patient information: Erythema nodosum (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/40/24196?source=see_link\">",
"       \"Patient information: Crohn's disease (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extraintestinal manifestations of inflammatory bowel disease (IBD) are common. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The association with disease activity and response to treatment of the underlying IBD are variable depending upon the specific extraintestinal manifestation. As general rules, erythema nodosum and episcleritis parallel disease activity while pyoderma gangrenosum and uveitis may not.",
"     </li>",
"     <li>",
"      Erythema nodosum typically appears as raised, tender, red or violet subcutaneous nodules on the extensor surfaces of extremities. As erythema nodosum usually parallels intestinal disease activity, treatment is directed at the underlying IBD. If skin nodules precede any bowel symptoms, or occur during quiescent phases of IBD, therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      may be required. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Erythema nodosum'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pyoderma gangrenosum lesions may appear as erythematous papules or pustules that are often preceded by trauma to the skin. Subsequent necrosis of the dermis leads to the development of deep ulcers. Therapy directed at the underlying IBD usually results in healing, although treatment often requires high dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or pulse",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      . Proctocolectomy in the setting of extensive colitis may be considered for those with severe pyoderma gangrenosum that is refractory to medical therapy. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pyoderma gangrenosum'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Episcleritis/scleritis",
"      </span>",
"      may be asymptomatic or result in burning and itching of the eyes. Injection of the ciliary vessels, inflammation of the episcleral tissues and episcleral nodules may be seen on slit-lamp examination. Therapy is directed at the underlying IBD and topical glucocorticoids for episcleritis or systemic therapy for scleritis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Episcleritis/scleritis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Uveitis is frequently bilateral, insidious in onset, and chronic in duration. Patients have eye pain, blurred vision, photophobia, and headaches. Secondary glaucoma and rarely blindness may occur if correct management is delayed. Prompt diagnosis and therapy with topical or systemic steroids is required. A topical mydriatic such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/31/33264?source=see_link\">",
"       scopolamine",
"      </a>",
"      (0.25 percent) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/34/24100?source=see_link\">",
"       cyclopentolate",
"      </a>",
"      (1 percent) may help relieve spasm.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       Infliximab",
"      </a>",
"      can be effective in patients with refractory disease. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Uveitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many other skin lesions (eg, Sweet syndrome, necrotizing cutaneous vasculitis, psoriasis, epidermolysis bullosa acquisita, metastatic Crohn's disease skin lesions, and non-melanoma skin cancer) and eye conditions (eg, cataracts, retinal vascular disease, subepithelial keratopathy, peripheral corneal ulcers, corneal infiltrates and central serous chorioretinopathy) may be seen in patients with IBD. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Miscellaneous skin lesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Miscellaneous eye conditions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/1\">",
"      Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/2\">",
"      Ricart E, Panaccione R, Loftus EV Jr, et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2004; 10:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/3\">",
"      Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 2008; 87:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/4\">",
"      Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/5\">",
"      Keltz M, Lebwohl M, Bishop S. Peristomal pyoderma gangrenosum. J Am Acad Dermatol 1992; 27:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/6\">",
"      Thornton JR, Teague RH, Low-Beer TS, Read AE. Pyoderma gangrenosum and ulcerative colitis. Gut 1980; 21:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/7\">",
"      von den Driesch P, Gomez RS, Kiesewetter F, Hornstein OP. Sweet's syndrome: clinical spectrum and associated conditions. Cutis 1989; 44:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/8\">",
"      Chiu G, Rajapakse CN. Cutaneous polyarteritis nodosa and ulcerative colitis. J Rheumatol 1991; 18:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/9\">",
"      Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003; 48:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/10\">",
"      Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990; 85:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/11\">",
"      Scarpa R, Manguso F, D'Arienzo A, et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 2000; 27:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/12\">",
"      Fidder H, Schnitzler F, Ferrante M, et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut 2009; 58:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/13\">",
"      Cheesbrough MJ. Epidermolysis bullosa acquisita and Crohn's disease. Br J Dermatol 1978; 99:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/14\">",
"      Burgdorf W. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol 1981; 5:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/15\">",
"      Tweedie JH, McCann BG. Metastatic Crohn's disease of thigh and forearm. Gut 1984; 25:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/16\">",
"      Abide JM. Metastatic Crohn disease: clearance with metronidazole. J Am Acad Dermatol 2011; 64:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/17\">",
"      Singh H, Nugent Z, Demers AA, Bernstein CN. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. Gastroenterology 2011; 141:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/18\">",
"      Long MD, Martin CF, Pipkin CA, et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012; 143:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/19\">",
"      Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011; 141:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/20\">",
"      Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 1982; 14:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/21\">",
"      Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997; 115:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/22\">",
"      Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 2005; 123:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/23\">",
"      Ruby AJ, Jampol LM. Crohn's disease and retinal vascular disease. Am J Ophthalmol 1990; 110:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/24\">",
"      Knox DL, Snip RC, Stark WJ. The keratopathy of Crohn's disease. Am J Ophthalmol 1980; 90:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/25\">",
"      Schulman MF, Sugar A. Peripheral corneal infiltrates in inflammatory bowel disease. Ann Ophthalmol 1981; 13:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41350/abstract/26\">",
"      Kaneko E, Nawano M, Honda N, et al. Ulcerative colitis complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment. Dig Dis Sci 1985; 30:896.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4064 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-3BFBD2B80D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41350=[""].join("\n");
var outline_f40_24_41350=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SKIN MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pyoderma gangrenosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Miscellaneous skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EYE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Episcleritis/scleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Uveitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Miscellaneous eye conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4064\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4064|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/46/8943\" title=\"picture 1\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/17/39187\" title=\"picture 2\">",
"      Pyoderma gangrenosum early",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/47/7920\" title=\"picture 3\">",
"      Pyoderma gangrenosum cribriform",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/55/27508\" title=\"picture 4\">",
"      Skin bx pyoderma gangrenosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/25/16799\" title=\"picture 5A\">",
"      Diffuse episcleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/48/26383\" title=\"picture 5B\">",
"      Nodular episcleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/3/33854\" title=\"picture 6\">",
"      Anterior uveitis in a patient with IBD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4064|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/32/28173\" title=\"table 1\">",
"      Extraintestinal manifest IBD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/32/22023?source=related_link\">",
"      Clinical manifestations and diagnosis of scleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/80?source=related_link\">",
"      Episcleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13130?source=related_link\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30393?source=related_link\">",
"      Neutrophilic dermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/40/24196?source=related_link\">",
"      Patient information: Crohn's disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/24/20866?source=related_link\">",
"      Patient information: Erythema nodosum (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/61/10202?source=related_link\">",
"      Pyoderma gangrenosum: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/15/11511?source=related_link\">",
"      Treatment of scleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/16/23817?source=related_link\">",
"      Uveitis: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/10/10407?source=related_link\">",
"      Uveitis: Treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_24_41351="Contact dermatitis impetiginized";
var content_f40_24_41351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Allergic contact dermatitis with secondary bacterial infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 359px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Impetigized allergic contact dermatitis in a 58-year-old man: pustules and honey-colored crusts cover an erythematous and edematous skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permisison from: the Dermatology Online Atlas,",
"     <a href=\"file://www.dermis.net\" target=\"_blank\">",
"      www.dermis.net",
"     </a>",
"     . Copyright &copy; 2011. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41351=[""].join("\n");
var outline_f40_24_41351=null;
var title_f40_24_41352="Diagnostic approach to infective endocarditis";
var content_f40_24_41352=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic approach to infective endocarditis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41352/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/24/41352/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of infective endocarditis (IE) is usually based upon a constellation of clinical findings rather than a single definitive test result. The diagnosis is usually obvious when a patient has the characteristic findings of IE:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Several positive blood cultures in the presence of a well recognized predisposing cardiac lesion",
"     </li>",
"     <li>",
"      Evidence of endocardial involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, some patients with IE do not have positive blood cultures (ie, culture-negative endocarditis), and approximately one-third to one-fourth of patients have no identifiable predisposing cardiac lesion at disease onset. The presence of atypical features may result in misdiagnosis or a correct diagnosis that is delayed. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Culture-negative endocarditis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The general approach to the diagnosis of IE will be reviewed here. Risk factors for IE and antibiotic prophylaxis and treatment of IE are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/31/14840?source=see_link\">",
"     \"Epidemiology, risk factors and microbiology of infective endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/37/20058?source=see_link\">",
"     \"Antimicrobial therapy of native valve endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/57/34712?source=see_link\">",
"     \"Antimicrobial therapy of prosthetic valve endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of infective endocarditis (IE) is usually based upon a combination of factors, including a careful history and physical examination, blood cultures and other selected laboratory results, an electrocardiogram (ECG), a chest radiograph, and an echocardiogram.",
"   </p>",
"   <p>",
"    Practical and logical case definitions are important since under-diagnosis can lead to clinical catastrophe and death, while overdiagnosis can result in weeks of unnecessary antimicrobial therapy with excessive costs and potentially avoidable drug-related side effects. It can, for example, be difficult to distinguish between IE and an alternate source of infection in a bacteremic patient with underlying heart disease.",
"   </p>",
"   <p>",
"    Several sets of criteria for IE have been described. The most commonly accepted are the revised Duke criteria (",
"    <a class=\"graphic graphic_table graphicRef73023 \" href=\"mobipreview.htm?9/26/9644\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"     table 2",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?4/35/4656?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31094?source=see_link&amp;anchor=H5#H5\">",
"     \"Infective endocarditis: Historical and Duke criteria\", section on 'Duke criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the initial assessment of patients with suspected endocarditis, a careful history should be performed with special attention given to a history of prior cardiac lesions and historical clues pointing toward a recent source of bacteremia, such as indwelling intravascular catheters or intravenous drug use.",
"   </p>",
"   <p>",
"    With the rise in rates of infective endocarditis (IE) due to S. aureus in the 21st century, IE is more often presents as acute rather than chronic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/31/14840?source=see_link\">",
"     \"Epidemiology, risk factors and microbiology of infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include a careful cardiac examination for signs of new regurgitant murmurs or heart failure (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A vigorous search should be undertaken for the classic clinical stigmata of endocarditis, including evidence of small and large emboli with special attention to the fundi, conjunctivae, skin, and digits. A neurologic evaluation may reveal evidence of focal neurologic impairment; it is also useful as a baseline examination should such abnormalities appear later. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link\">",
"     \"Complications and outcome of infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Associated peripheral cutaneous or mucocutaneous lesions of infective endocarditis (IE) include petechiae, splinter hemorrhages, Janeway lesions, Osler's nodes, and Roth spots. Petechiae are not specific for IE but are its most common skin manifestation (",
"    <a class=\"graphic graphic_picture graphicRef57118 \" href=\"mobipreview.htm?32/29/33235\">",
"     picture 1",
"    </a>",
"    ). They may be present on the skin, usually on the extremities, or on mucous membranes such as the palate or conjunctivae, the latter usually as hemorrhages best seen with eversion of either upper or lower eyelids. Splinter hemorrhages, also nonspecific for endocarditis, are nonblanching, linear reddish-brown lesions found under the nail bed (",
"    <a class=\"graphic graphic_picture graphicRef72076 \" href=\"mobipreview.htm?15/63/16369\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Janeway lesions, Osler's nodes, and Roth spots are more specific (but still not diagnostic) for IE. All three findings are uncommon in modern practice.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Janeway lesions are macular, nonpainful, erythematous lesions on the palms and soles (",
"      <a class=\"graphic graphic_picture graphicRef58380 \" href=\"mobipreview.htm?30/54/31585\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Osler's nodes are painful, violaceous nodules found in the pulp of fingers and toes and are seen more often in subacute than acute cases of IE (",
"      <a class=\"graphic graphic_picture graphicRef68796 \" href=\"mobipreview.htm?28/10/28847\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Roth spots are exudative, edematous hemorrhagic lesions of the retina.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these physical findings, patients with IE may have involvement of other organs due to embolic events (eg, focal neurologic deficits, renal and splenic infarcts) or a systemic immune reaction (eg, glomerulonephritis, arthritis). In right-sided endocarditis, septic pulmonary infarcts may be seen (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80439 \" href=\"mobipreview.htm?20/49/21266\">",
"     image 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link\">",
"     \"Complications and outcome of infective endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5556?source=see_link\">",
"     \"Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LABORATORY STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood cultures should be obtained prior to antibiotic therapy. Their importance was illustrated in a prospective study of 348 patients with suspected culture-negative endocarditis; among the 73 patients without an identifiable etiologic agent, 58 (79 percent) received antibiotics before blood cultures were obtained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A minimum of three blood cultures should be obtained over a time period based upon the severity of the illness. If the tempo of illness is subacute and the patient is not critically ill, it is reasonable and often preferable to delay therapy for one to three days while awaiting the results of blood cultures and other diagnostic tests. However, if the patient is acutely ill, three blood cultures should be obtained over a one-hour time span before beginning empiric therapy. Almost all cases of bacterial infective endocarditis (IE) are due to aerobic organisms; thus, culturing for anaerobes is rarely useful or necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=see_link\">",
"     \"Blood cultures for the detection of bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The additional diagnostic yield of more than three cultures is minimal in patients who have not recently received antimicrobial therapy. In a series of 206 cases of endocarditis, for example, the initial blood culture in patients with streptococcal endocarditis was positive in 96 percent and one of the first two blood cultures was positive in 98 percent; in patients with IE caused by bacteria other than streptococci, the first blood culture was positive in 82 percent and one of the first two cultures was positive in 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/3\">",
"     3",
"    </a>",
"    ]. Additional blood cultures are occasionally useful in patients who have been treated recently with antibiotics.",
"   </p>",
"   <p>",
"    The bacteriologic diagnosis of IE is facilitated by the relative constancy, rather than random, release of bacteria from the cardiac vegetations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/4\">",
"     4",
"    </a>",
"    ]. However, since many patients with bacterial endocarditis have low grade bacteremia (eg, 1 to 10",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    of blood) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/3\">",
"     3",
"    </a>",
"    ], a minimum of 10 mL (and preferably 20 mL) of blood should be obtained from adults and 0.5 to 5 mL from infants and children. In one study, blood cultures inoculated with at least 5 mL of blood had a significantly higher detection rate for bacteremia than bottles inoculated with less than 5 mL of blood (92 versus 69 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/5\">",
"     5",
"    </a>",
"    ]. The estimated yield of blood cultures in bacteremic adults increased approximately 3 percent per mL of blood cultured.",
"   </p>",
"   <p>",
"    Each set of cultures should be obtained from separate venipuncture sites, and, when possible, blood cultures should not be obtained from preexisting vascular catheters. Blood cultures can be taken at any time; they do not need to be obtained with the appearance of chills or fever since patients with IE typically have a continuous bacteremia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=see_link\">",
"     \"Blood cultures for the detection of bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Organism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not all microorganisms have the same propensity to cause endocarditis. As an example, organisms such as viridans streptococci and Staphylococcus aureus are more likely to cause endocarditis than are gram-negative rods such as Escherichia coli and Proteus spp. This distinction is important. The Duke Criteria for the diagnosis of endocarditis define the following organisms as \"typical causes\" of IE (",
"    <a class=\"graphic graphic_table graphicRef73023 \" href=\"mobipreview.htm?9/26/9644\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Staphylococcus aureus",
"     </li>",
"     <li>",
"      Viridans streptococci and Streptococcus bovis",
"     </li>",
"     <li>",
"      Enterococci",
"     </li>",
"     <li>",
"      HACEK group organisms (",
"      <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It was previously thought that patients who present with community-acquired enterococcal bacteremia are significantly more likely to have endocarditis than patients who develop enterococcal bacteremia while hospitalized for another cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/7\">",
"     7",
"    </a>",
"    ]. However, this conclusion has been questioned as a result of a case-control study that compared the clinical and demographic characteristics of all patients with enterococcal endocarditis seen at a single center over eight years with controls randomly chosen from 455 patients with enterococcal bacteremia without endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/8\">",
"     8",
"    </a>",
"    ]. Community acquisition of bacteremia was not a risk factor for IE.",
"   </p>",
"   <p>",
"    The probability of endocarditis varies by species of bacteria. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      S. sanguis bacteremia is more often indicative of endocarditis than is bacteremia due to S. milleri (also known as S. anginosus).",
"     </li>",
"     <li>",
"      Bacteremia with groups A or C streptococci are seldom associated with IE whereas group G streptococcal infection is often indicative of endocarditis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27080?source=see_link\">",
"       \"Group C and group G streptococcal infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a study of enterococcal bacteremia cited above, infection with E. faecalis, compared to other enterococcal species, was associated with IE by both univariate and multivariate analysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of endocarditis in patients with S. aureus bacteremia (regardless of source or residence at the time of onset) is particularly high. As a result,",
"    <strong>",
"     all",
"    </strong>",
"    patients with S. aureus recovered from the blood should be clinically evaluated for IE. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/1/26649?source=see_link\">",
"     \"Complications of Staphylococcus aureus bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Positive cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interpretation of positive blood cultures in patients with suspected endocarditis is confounded by the fact that false-positive results occasionally occur despite use of the most exacting techniques for collection and processing. When organisms such as Propionibacterium spp, Corynebacterium spp, Bacillus spp, and coagulase-negative staphylococci are recovered from a single blood culture or a minority of blood culture bottles, the result is probably falsely positive. However, since all of these organisms are capable of causing endocarditis, it is important to determine if the bacteremia is persistent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5317?source=see_link\">",
"     \"Endocarditis due to coagulase-negative staphylococci\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The definition of persistent bacteremia varies with the likelihood that the organism is a cause of endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For an organism likely to cause endocarditis (eg, S. aureus, viridans streptococci),",
"      <strong>",
"       two",
"      </strong>",
"      positive samples collected more than 12 hours apart",
"     </li>",
"     <li>",
"      For an organism that is more commonly a skin contaminant,",
"      <strong>",
"       three",
"      </strong>",
"      or a majority of four or more separate blood cultures are positive and the first and last samples are collected at least one hour apart",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The utility of other laboratory tests in the diagnosis of endocarditis is limited, other than the finding of an antiphase I IgG titer &gt;1:800 for Coxiella burnetii [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following findings may be identified among patients with IE but are relatively nonspecific:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An elevated erythrocyte sedimentation rate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an elevated level of C-reactive protein.",
"     </li>",
"     <li>",
"      A normochromic normocytic anemia.",
"     </li>",
"     <li>",
"      The white blood cell count may be normal or elevated in patients with subacute presentations of endocarditis; however, most patients with staphylococcal endocarditis have leukocytosis and some may have thrombocytopenia.",
"     </li>",
"     <li>",
"      Hyperglobulinemia, cryoglobulins, circulating immune complexes, hypocomplementemia, elevated rheumatoid factor titers, and false positive serologic tests for syphilis all occur in some patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An elevated rheumatoid factor titer in patients without a known prior rheumatologic disorder is one of six minor criteria in the Duke diagnostic scheme (",
"    <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/41/42648?source=see_link\">",
"     \"Origin and utility of measurement of rheumatoid factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients with endocarditis have an abnormal urinalysis, as manifested by microscopic or gross hematuria, proteinuria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pyuria. Each of these findings lacks specificity. However, the presence of red blood cell casts on urinalysis is generally indicative of glomerulonephritis (often in association with hypocomplementemia) and is a minor diagnostic criterion for IE (",
"    <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5556?source=see_link\">",
"     \"Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CARDIAC STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that a baseline electrocardiogram be performed as part of the initial evaluation of all patients with suspected endocarditis even though this test rarely shows diagnostic findings. The presence or subsequent appearance of changes suggestive of ischemia or infarction on the electrocardiogram may provide useful clues to the presence of emboli to the coronary circulation. In addition, the initial presence or new appearance of heart block or conduction delay may provide an important clue to extension of infection to the valve annulus and adjacent septum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link\">",
"     \"Complications and outcome of infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographs occasionally reveal important diagnostic clues. As an example, patients with tricuspid valve endocarditis often present with radiographic evidence of septic pulmonary emboli. In such cases, there may be a few or multiple focal lung infiltrates, which may reveal central cavitation. Rarely, chest radiographs show calcification in a cardiac valve, which may raise suspicions of endocarditis in a febrile patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of patients with valvular heart disease included recommendations for the use of transthoracic and transesophageal echocardiography in patients with suspected or proven native or prosthetic valve endocarditis (",
"    <a class=\"graphic graphic_table graphicRef60777 \" href=\"mobipreview.htm?32/34/33324\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/11\">",
"     11",
"    </a>",
"    ]. These recommendations are generally consistent with the 2005 AHA guidelines on infective endocarditis, which were endorsed by the Infectious Diseases Society of America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The information that can be obtained by echocardiography includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of patients in settings in which endocarditis is suspected (such as persistent bacteremia without a known source or high clinical suspicion with negative cultures)",
"     </li>",
"     <li>",
"      Detection and characterization of vegetations on valves and in other sites (as in patients with congenital heart disease)",
"     </li>",
"     <li>",
"      Detection of valvular dysfunction and assessment of hemodynamic severity",
"     </li>",
"     <li>",
"      Detection of associated abnormalities such as shunts or abscesses",
"     </li>",
"     <li>",
"      Re-evaluation of patients in complex settings (such as those with virulent organisms, severe hemodynamic effects, persistent or recurrent fever or bacteremia, or clinical deterioration)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An echocardiogram should be performed in all patients with a moderate or high suspicion of endocarditis (",
"    <a class=\"graphic graphic_table graphicRef73023 \" href=\"mobipreview.htm?9/26/9644\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"     table 2",
"    </a>",
"    ). In comparison, among patients with a low clinical probability of endocarditis, the diagnostic yield of both transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) is very low, and neither should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31094?source=see_link&amp;anchor=H2#H2\">",
"     \"Infective endocarditis: Historical and Duke criteria\", section on 'Case definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Role of TTE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transthoracic echocardiography may provide confirmation of the diagnosis of endocarditis. Detection of a vegetation is a positive test (",
"    <a class=\"graphic graphic_movie graphicRef52651 \" href=\"mobipreview.htm?30/9/30867\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef79209 \" href=\"mobipreview.htm?21/28/21954\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef55154 \" href=\"mobipreview.htm?21/47/22260\">",
"     movie 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=see_link\">",
"     \"Role of echocardiography in infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, TTE has relatively low sensitivity for vegetation in infective endocarditis (IE) (29 to 63 percent in different series) although the specificity approaches 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/14\">",
"     14",
"    </a>",
"    ]. Thus, the absence of vegetation does",
"    <strong>",
"     not",
"    </strong>",
"    preclude the diagnosis and, as described in the next section, TEE is usually warranted. However, the finding of normal valves (both morphology and function) substantially reduces the probability of IE. In one study, 96 percent of patients with normal valves and no vegetation on TTE also had a negative TEE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Role of TEE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transesophageal echocardiography has a higher spatial resolution than TTE and is much more sensitive for the detection of endocarditis (",
"    <a class=\"graphic graphic_movie graphicRef65848 \" href=\"mobipreview.htm?29/38/30306\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58456 \" href=\"mobipreview.htm?17/39/18035\">",
"     movie 5",
"    </a>",
"    ). TEE is especially useful for the detection of vegetations, diagnosis of prosthetic valve endocarditis, detection of a valve abscess, and assessment of embolic risk.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Detection of vegetations &mdash; Two series with a total of 162 episodes of suspected IE demonstrated the greater sensitivity of TEE compared to TTE (100 versus 63 percent and 94 versus 44 percent, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/14,16\">",
"       14,16",
"      </a>",
"      ]. In a third report of 103 patients with S. aureus bacteremia, TTE revealed valvular abnormalities in 33 patients and vegetations in seven; in contrast, TEE identified vegetations in 22 patients and abscesses in two [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diagnosis of IE on prosthetic valves &mdash; TEE is especially important for prosthetic valves in the mitral or aortic position, because acoustic shadowing frequently makes the transthoracic approach suboptimal. TEE has superior spatial resolution, and bacteremic patients with these prostheses are at increased risk for endocarditis (",
"      <a class=\"graphic graphic_movie graphicRef58762 \" href=\"mobipreview.htm?40/16/41230\">",
"       movie 6",
"      </a>",
"      ). Few data are available regarding the superiority of TEE for suspected endocarditis of tricuspid and pulmonic prostheses, but presumably it would be similar. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=see_link&amp;anchor=H26#H26\">",
"       \"Role of echocardiography in infective endocarditis\", section on 'Prosthetic valve endocarditis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The greater value of TEE in patients with prosthetic heart valves was demonstrated in a prospective study that compared TTE and TEE in 114 episodes of IE suspected on clinical grounds (80 on native valves and 34 on prosthetic valves) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/18\">",
"       18",
"      </a>",
"      ]. The results of the two tests were concordant in 55 percent of cases; TEE led to a reclassification in 11 percent of patients with native valves and 34 percent with prosthetic valves.",
"      <br/>",
"      <br/>",
"      The negative predictive value of TEE is nearly 100 percent for patients with native valves, but IE can be missed in patients with prosthetic valves. In the latter patients, clinical assessment is especially important.",
"     </li>",
"     <li>",
"      Detection of a valve abscess &mdash; TEE is much more sensitive than TTE for the detection of valve abscess. This was illustrated in a series of 44 patients with IE complicated by abscess formation (sensitivity 87 versus 28 percent with TTE) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/19\">",
"       19",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      While TEE is generally much more sensitive than TTE for detection of abscess, even TEE may miss a significant number of abscesses in some populations. This was illustrated in a report of 44 patients with endocarditis by Duke criteria who had valvular abscesses identified intraoperatively. Endocarditis was detected by TEE in only 48 percent of cases; prosthetic heart valves were present in 32 percent of patients. Indications for surgery included severe valvular dysfunction (with or without heart failure), embolization during antibiotic therapy, or concomitant pacemaker infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/20\">",
"       20",
"      </a>",
"      ]. Abscesses not visualized by TEE were located at the posterior mitral annulus in 61 percent of cases; the majority of these were associated with a large calcification, which may have interfered with detection.",
"     </li>",
"     <li>",
"      Assessment of embolic risk &mdash; In general, larger vegetation size is associated with increased risk of embolization. This issue is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=see_link&amp;anchor=H17#H17\">",
"       \"Role of echocardiography in infective endocarditis\", section on 'Echocardiographic estimation of outcome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Recommended use",
"    </span>",
"    &nbsp;&mdash;&nbsp;We generally perform a TTE as the first diagnostic test in most patients with suspected IE. However, it is reasonable to begin with TEE in selected settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Limited transthoracic windows (eg, due to obesity, chest wall deformity, or mechanical ventilation)",
"     </li>",
"     <li>",
"      Prosthetic valves, especially prosthetic aortic or mitral valves in which shadowing may make visualization difficult by TTE",
"     </li>",
"     <li>",
"      A prior valvular abnormality (including previous endocarditis)",
"     </li>",
"     <li>",
"      S. aureus bacteremia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bacteremia due to an organism known to be a common cause of IE such as viridans streptococci",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with a normal TTE (both morphology and function), the likelihood of IE is very low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/15\">",
"     15",
"    </a>",
"    ]. A subsequent TEE is not necessary unless one or more of the following is present:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A high clinical suspicion of IE (persistently positive blood cultures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      multiple minor criteria for endocarditis) (",
"      <a class=\"graphic graphic_table graphicRef73023 \" href=\"mobipreview.htm?9/26/9644\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef53004 \" href=\"mobipreview.htm?6/31/6653\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A technically limited TTE study",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients with abnormal on findings on TTE may require further evaluation by TEE. These include patients with significant valvular regurgitation in whom surgery is contemplated and patients who have one or more of the following risk factors for perivalvular abscess:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Conduction delay by ECG that is not known to be old",
"     </li>",
"     <li>",
"      Persistent fever despite appropriate antimicrobial therapy",
"     </li>",
"     <li>",
"      Aortic valve endocarditis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link&amp;anchor=H5#H5\">",
"     \"Complications and outcome of infective endocarditis\", section on 'Perivalvular abscesses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Controversies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of unresolved controversies related to the use of echocardiography in the diagnosis and management of patients with IE:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some experts recommend that all patients with suspected IE, especially those with staphylococcal bacteremia should have a TEE as the initial study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/21\">",
"       21",
"      </a>",
"      ]. However, we regard the steps outlined above as sufficient to exclude IE without TEE in many cases, and do not require that all patients undergo this invasive procedure.",
"     </li>",
"     <li>",
"      Some experts believe that patients with staphylococcal bacteremia associated with a condition (such as vertebral osteomyelitis) that will require a protracted course of antimicrobial therapy do not require echocardiography to rule out associated IE, especially if there are no hemodynamic signs or symptoms of IE. However, we recommend that echocardiography be performed in such patients, since a positive result will influence the type and intensity of follow-up examinations. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link\">",
"       \"Complications and outcome of infective endocarditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      On theoretical grounds, some physicians delay echocardiography for several days after the onset of bacteremia, because both TTE and TEE can be falsely negative if vegetations are small (and, occasionally, if previously present vegetations have embolized). In addition, even TEE can miss a perivalvular abscess, especially if the study is done in the first few days of illness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2005 AHA guidelines on the diagnosis and management of IE, which were endorsed by the Infectious Diseases Society of America, recommend that echocardiography be performed as soon as possible after the diagnosis of IE is suspected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/12\">",
"     12",
"    </a>",
"    ]. Similar recommendations have been made by the British Society for Antimicrobial Chemotherapy (BSAC) in their 2012 guidelines for diagnosis and antibiotic treatment of endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cardiac computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary data suggest that multislice CT may emerge as a useful tool for evaluation of IE. A study of 37 patients with suspected IE compared the diagnostic accuracy of multislice computed tomography (CT) with TEE and intraoperative findings for valvular and perivalvular abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/24\">",
"     24",
"    </a>",
"    ]. CT correctly identified 26 of 27 patients with vegetations and 9 of 9 patients with",
"    <span class=\"nowrap\">",
"     abscesses/pseudoaneurysms",
"    </span>",
"    but none of four valve perforations.",
"   </p>",
"   <p>",
"    However, echocardiography has generally greater sensitivity for structures with chaotic motion such as vegetations than computed tomography and cardiovascular magnetic resonance. In addition, the cost and radiation exposure involved in computed tomography makes this imaging less useful than echocardiography in detecting vegetations and intracardiac abnormalities in patients with known or suspected IE in daily practice.",
"   </p>",
"   <p>",
"    The potential role of multislice CT or cardiovascular magnetic resonance for other cardiac conditions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20906?source=see_link\">",
"     \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Valve culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valve culture is useful only if there are other clinical signs and symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    echocardiographic findings that suggest the presence of IE; routine culture of heart valves removed at the time of surgery can lead to false positive results. In one study including 1030 valves removed at surgery, cultures were positive in 25 percent of patients that met Duke criteria for IE and in 28 percent of patients without other criteria for IE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Valve histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic demonstration of microorganisms, vegetations, or active endocarditis in cardiac valve tissue obtained at surgery is included in the Duke criteria and is considered to be a criterion of confirmed infective endocarditis (",
"    <a class=\"graphic graphic_table graphicRef73023 \" href=\"mobipreview.htm?9/26/9644\">",
"     table 1",
"    </a>",
"    ). The histologic features that characterize endocarditis were defined in a retrospective pathologic analysis of tissue adjoining mechanical cardiac valves in 90 patients who underwent surgical removal of a mechanical valve for suspected IE (21 patients) or noninfectious dysfunction (69 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IE was characterized by microorganisms, vegetations, and significant neutrophil-rich inflammatory infiltrates with extensive neovascularization. In contrast, tissue adjoining valves from noninfectious complications showed extensive fibrosis and, when present, inflammatory infiltrates that were mainly composed of macrophages and lymphocytes.",
"   </p>",
"   <p>",
"    Thus, when no microorganisms are detected and vegetations are lacking in tissue adjacent to a mechanical valve, neutrophil-rich inflammation and extensive neovascularization may allow differentiation between IE and inflammatory noninfectious valve processes in patients with mechanical cardiac valves who undergo surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cerebral imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine magnetic resonance imaging (MRI) may be useful in patients with definite or suspected IE. In one study including 53 patients, early use of cerebral MRI led to the reclassification from possible to definite IE in one-third of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41352/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CULTURE-NEGATIVE ENDOCARDITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Culture-negative endocarditis should be considered in patients with negative blood cultures and persistent fever with one or more clinical findings consistent with infective endocarditis (IE) (eg, stroke or other manifestations of emboli). Culture-negative IE should also be considered in patients with a vegetation on echocardiogram with no clear microbiologic diagnosis. Issues related to culture-negative IE are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34646?source=see_link\">",
"     \"Culture-negative endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard antimicrobial therapy for infective endocarditis is generally administered to patients characterized as definite or probable by the Duke criteria. Patients in whom the diagnosis is \"rejected\" by these criteria are not usually treated with prolonged antimicrobial therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/37/20058?source=see_link\">",
"     \"Antimicrobial therapy of native valve endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/48/26370?source=see_link\">",
"       \"Patient information: Endocarditis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of infective endocarditis (IE) is usually based upon a constellation of history, clinical findings, laboratory studies (particularly blood cultures), and echocardiography. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical examination findings supporting a diagnosis of IE include new regurgitant murmurs or heart failure, evidence of embolic events (eg, focal neurologic impairment, glomerulonephritis, renal and splenic infarcts, and septic pulmonary infarcts), and peripheral cutaneous or mucocutaneous lesions (eg, petechiae, conjunctival or splinter hemorrhages, Janeway lesions, Osler's nodes, and Roth spots). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As part of the initial evaluation of all patients with suspected endocarditis the following studies should be performed:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      At least three blood cultures from separate sites over a time period ranging from a few hours to one to two days depending upon the severity of illness and urgency of the need for treatment. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Blood cultures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An electrocardiogram to evaluate for the presence of changes suggestive of ischemia or infarction or the presence or new appearance of heart block or conduction delay. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Electrocardiogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Echocardiography. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cultures remain negative in 2 to 5 percent of patients with endocarditis, which is referred to as culture-negative endocarditis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34646?source=see_link\">",
"       \"Culture-negative endocarditis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/1\">",
"      Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/2\">",
"      Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/3\">",
"      Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA 1967; 202:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/4\">",
"      Beeson PB, Brannon ES, Warren JV. OBSERVATIONS ON THE SITES OF REMOVAL OF BACTERIA FROM THE BLOOD IN PATIENTS WITH BACTERIAL ENDOCARDITIS. J Exp Med 1945; 81:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/5\">",
"      Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/6\">",
"      Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/7\">",
"      Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/8\">",
"      Anderson DJ, Murdoch DR, Sexton DJ, et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection 2004; 32:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/9\">",
"      Parker MT, Ball LC. Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 1976; 9:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/10\">",
"      Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/11\">",
"      American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease), Society of Cardiovascular Anesthesiologists, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/12\">",
"      Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/13\">",
"      Lindner JR, Case RA, Dent JM, et al. Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation 1996; 93:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/14\">",
"      Shively BK, Gurule FT, Roldan CA, et al. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/15\">",
"      Irani WN, Grayburn PA, Afridi I. A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis. Am J Cardiol 1996; 78:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/16\">",
"      Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 1988; 9:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/17\">",
"      Fowler VG Jr, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/18\">",
"      Roe MT, Abramson MA, Li J, et al. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria. Am Heart J 2000; 139:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/19\">",
"      Daniel WG, M&uuml;gge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/20\">",
"      Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J 2007; 154:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/21\">",
"      Heidenreich PA, Masoudi FA, Maini B, et al. Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med 1999; 107:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/22\">",
"      Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991; 18:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/23\">",
"      Gould FK, Denning DW, Elliott TS, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012; 67:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/24\">",
"      Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 2009; 53:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/25\">",
"      Mu&ntilde;oz P, Bouza E, Mar&iacute;n M, et al. Heart valves should not be routinely cultured. J Clin Microbiol 2008; 46:2897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/26\">",
"      Lepidi H, Casalta JP, Fournier PE, et al. Quantitative histological examination of mechanical heart valves. Clin Infect Dis 2005; 40:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41352/abstract/27\">",
"      Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010; 152:497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2143 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-189.41.172.26-77D38C6D5A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41352=[""].join("\n");
var outline_f40_24_41352=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSTIC CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LABORATORY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Collection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Organism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Positive cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CARDIAC STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Role of TTE",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Role of TEE",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Recommended use",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Controversies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cardiac computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Valve culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Valve histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cerebral imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CULTURE-NEGATIVE ENDOCARDITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2143\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2143|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/49/21266\" title=\"diagnostic image 1\">",
"      Pulmonary embolism IE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2143|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/29/33235\" title=\"picture 1\">",
"      Petechiae in subacute bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/63/16369\" title=\"picture 2\">",
"      Splinter hemorrhages in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/54/31585\" title=\"picture 3\">",
"      Janeway lesion in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/10/28847\" title=\"picture 4\">",
"      Oslers nodes in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2143|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?30/9/30867\" title=\"movie 1\">",
"      Parasternal long axis echo aortic valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?21/28/21954\" title=\"movie 2\">",
"      Parasternal long axis echo close up aortic valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?21/47/22260\" title=\"movie 3\">",
"      Aortic valve endocarditis long axis color Doppler echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?29/38/30306\" title=\"movie 4\">",
"      TEE mitral valve aneurysm from endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?17/39/18035\" title=\"movie 5\">",
"      TEE mitral valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?40/16/41230\" title=\"movie 6\">",
"      TEE prosthetic mitral valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2143|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/26/9644\" title=\"table 1\">",
"      Duke criteria for IE I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/31/6653\" title=\"table 2\">",
"      Duke criteria for IE II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/34/33324\" title=\"table 3\">",
"      Guidelines for use of echocardiography in IE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?4/35/4656?source=related_link\" title=\"calculator 1\">",
"      Calculator: Diagnosis of endocarditis - Duke criteria for definite endocarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/37/20058?source=related_link\">",
"      Antimicrobial therapy of native valve endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/57/34712?source=related_link\">",
"      Antimicrobial therapy of prosthetic valve endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=related_link\">",
"      Blood cultures for the detection of bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=related_link\">",
"      Complications and outcome of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/1/26649?source=related_link\">",
"      Complications of Staphylococcus aureus bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34646?source=related_link\">",
"      Culture-negative endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5317?source=related_link\">",
"      Endocarditis due to coagulase-negative staphylococci",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/31/14840?source=related_link\">",
"      Epidemiology, risk factors and microbiology of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27080?source=related_link\">",
"      Group C and group G streptococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31094?source=related_link\">",
"      Infective endocarditis: Historical and Duke criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20906?source=related_link\">",
"      Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/41/42648?source=related_link\">",
"      Origin and utility of measurement of rheumatoid factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/48/26370?source=related_link\">",
"      Patient information: Endocarditis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5556?source=related_link\">",
"      Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=related_link\">",
"      Role of echocardiography in infective endocarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_24_41353="Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease";
var content_f40_24_41353=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     Csaba P Kovesdy, MD, FASN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/24/41353/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/24/41353/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3156775\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals produce approximately 15,000 mmol (considerably more with exercise) of carbon dioxide and 50 to 100 meq of nonvolatile acid each day. Acid-base balance is maintained by normal elimination of carbon dioxide by the lungs (which affects the partial pressure of carbon dioxide [PCO2]) and normal excretion of nonvolatile acid by the kidneys (which affects the plasma bicarbonate concentration). The hydrogen ion concentration of the blood is determined by the ratio of the PCO2 and plasma bicarbonate concentration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/41/27288?source=see_link&amp;anchor=H12584019#H12584019\">",
"     \"Simple and mixed acid-base disorders\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acidosis associated with chronic kidney disease (CKD) will be discussed in this topic. An overview of simple acid-base disorders and renal tubular acidosis, as well as the approach to patients with metabolic acidosis, are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/32/10759?source=see_link\">",
"     \"Overview of renal tubular acidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6330?source=see_link\">",
"     \"Approach to the child with metabolic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     ACID-BASE BALANCE IN CHRONIC KIDNEY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acid-base balance is normally maintained by the renal excretion of the daily acid load (about 1",
"    <span class=\"nowrap\">",
"     meq/kg",
"    </span>",
"    per day, derived mostly from the generation of sulfuric acid during the metabolism of sulfur-containing amino acids) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Elimination of this acid load is achieved by the urinary excretion of hydrogen ions, both as titratable acidity and as ammonium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/3\">",
"     3",
"    </a>",
"    ]. Near-normal balance can be maintained even if the acid load is modestly increased since net acid excretion rises appropriately, primarily via increased ammonium production and excretion (",
"    <a class=\"graphic graphic_figure graphicRef60880 \" href=\"mobipreview.htm?7/22/7533\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Development of metabolic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic acidosis can develop as a result of one or more of the following pathophysiologic processes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased production of nonvolatile acids",
"     </li>",
"     <li>",
"      Increased loss of bicarbonate",
"     </li>",
"     <li>",
"      Decreased renal excretion of acid",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Metabolic acidosis is commonly associated with chronic kidney disease (CKD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. As the number of functioning nephrons declines in CKD, acid excretion is initially maintained by an increase in the ammonium excreted per nephron [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1\">",
"     1",
"    </a>",
"    ]. However, total ammonium excretion begins to fall when the glomerular filtration rate (GFR) is below 40 to 50",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1,2,8\">",
"     1,2,8",
"    </a>",
"    ]. At this level of renal function, ammonium excretion per total GFR is three to four times above normal, suggesting that the impairment in ammonium excretion is caused by too few functioning nephrons rather than impaired function in the remaining nephrons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1,9\">",
"     1,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result, CKD leads to retention of hydrogen ions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1,6,8,10\">",
"     1,6,8,10",
"    </a>",
"    ]. In addition to the fall in ammonium excretion, diminished excretion of titratable acid (primarily as phosphoric acid) also may play a role in the pathogenesis of metabolic acidosis in patients with advanced kidney disease. Both dietary phosphate restriction and the use of oral phosphate binders to prevent hyperphosphatemia may contribute to the fall in phosphate excretion.",
"   </p>",
"   <p>",
"    The retained acid is buffered by bicarbonate in the extracellular fluid, by tissue buffers, and by bone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/11\">",
"     11",
"    </a>",
"    ]. With worsening renal function, however, progressive metabolic acidosis and acidemia can develop. As a result, metabolic acidosis and acidemia become more common with advancing stages of CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/12\">",
"     12",
"    </a>",
"    ]. The prevalence of a serum bicarbonate concentration of &lt;22",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    for example, is &lt;5 percent in CKD stages 1 and 2 and increases linearly to approximately 25 percent in patients with non-dialysis dependent CKD stage G5 (",
"    <a class=\"graphic graphic_table graphicRef70597 \" href=\"mobipreview.htm?13/47/14076\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/13\">",
"     13",
"    </a>",
"    ]. As the patient approaches end-stage renal disease (ESRD), the plasma bicarbonate concentration tends to stabilize between 12 and 20",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1,8,14\">",
"     1,8,14",
"    </a>",
"    ]. A level below 10",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    is unusual since buffering of the retained hydrogen ions prevents a progressive fall in the plasma bicarbonate concentration. Typically, the anion gap remains normal until late stages of CKD when it begins to widen due to the retention of anions such as phosphate, sulfate, urate, and hippurate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Dialysis patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initiation of renal replacement therapy typically results in improvement in metabolic acidosis as a result of the additional base load delivered in the dialysate, although metabolic acidosis can persist in patients who have higher net acid generation, typically those whose diet contains higher amounts of animal proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients undergoing maintenance dialysis have spuriously low plasma bicarbonate levels. If blood samples are transported from the dialysis clinic to the clinical laboratory by air freight, delayed centrifugation of the specimen may lead to increased lactic acid production by blood cells; this can artifactually reduce the plasma bicarbonate concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a small number of patients with ESRD have a normal plasma bicarbonate concentration and anion gap [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/14\">",
"     14",
"    </a>",
"    ]. A reduced daily acid load caused by decreased protein intake (which diminishes both acid and sulfate generation)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased fruit intake (which provides citrate that is converted to bicarbonate) are the most likely explanations. For unclear reasons, most patients with ESRD who have a normal plasma bicarbonate and a normal anion gap also have diabetes mellitus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A superimposed metabolic alkalosis (as occurs with vomiting or diuretic therapy) is another factor that could normalize the plasma bicarbonate concentration in advanced renal failure. In this setting, the anion gap should still be elevated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21526?source=see_link\">",
"     \"The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Renal transplant recipients",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mild metabolic acidosis is frequently observed among kidney transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/20\">",
"     20",
"    </a>",
"    ] even though the urinary acidification defects associated with CKD often resolve following allograft implantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/21\">",
"     21",
"    </a>",
"    ]. In one of the largest studies, the mean serum bicarbonate concentration was 22",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    among 823 unselected kidney transplant patients, with nearly 60 percent having levels less than 24",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/22\">",
"     22",
"    </a>",
"    ]. Decreased kidney function, increased parathyroid hormone and phosphate levels, and decreased serum albumin and calcium levels were associated with lower bicarbonate levels.",
"   </p>",
"   <p>",
"    Potential mechanisms responsible for post-transplant metabolic acidosis include the development of renal tubular acidosis (due, for example, to calcineurin inhibitors such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ), hyperkalemia, hypercalcemia, and disordered citrate metabolism and other tubular dysfunctions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/23-27\">",
"     23-27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link&amp;anchor=H11#H11\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\", section on 'Metabolic acidosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/18/25891?source=see_link&amp;anchor=H3#H3\">",
"     \"Potassium balance in acid-base disorders\", section on 'Metabolic acidosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical manifestations of hypercalcemia\", section on 'Renal tubular acidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H117255428\">",
"    <span class=\"h1\">",
"     CONSEQUENCES OF METABOLIC ACIDOSIS IN CKD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic metabolic acidosis in patients with chronic kidney disease (CKD) may produce a variety of pathophysiologic changes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bone resorption and osteopenia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/11,28-30\">",
"       11,28-30",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Aggravation of secondary hyperparathyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Reduced respiratory reserve and exhaustion of body buffer systems, resulting in increased severity of acute intercurrent illnesses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Reduced Na",
"      <sup>",
"       +",
"      </sup>",
"      -K",
"      <sup>",
"       +",
"      </sup>",
"      -ATPase activity in red blood cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/34\">",
"       34",
"      </a>",
"      ] and myocardial cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/35\">",
"       35",
"      </a>",
"      ], which could impair myocardial contractility and produce heart failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increased muscle protein catabolism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/7,37-41\">",
"       7,37-41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Endocrine disorders such as resistance to growth hormone and insulin, and hypertriglyceridemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/7,37,42\">",
"       7,37,42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Systemic inflammation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hypotension and malaise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11936141\">",
"    <span class=\"h2\">",
"     Association with mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies in patients with non-dialysis dependent CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/45,46\">",
"     45,46",
"    </a>",
"    ] and end-stage renal disease (ESRD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/47-49\">",
"     47-49",
"    </a>",
"    ] have described a significant association of metabolic acidosis with higher mortality. The following studies are representative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 1240 military veterans with non-dialysis dependent CKD, those whose serum bicarbonate was &lt;22",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      had a significantly higher risk of mortality as compared with those whose bicarbonate was 26 to 29",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (adjusted hazard ratio 1.43, 95% CI 1.10-1.87) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 56,385 patients on maintenance hemodialysis, the two-year mortality rate was lowest among those whose serum bicarbonate was 17 to 19",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/49\">",
"       49",
"      </a>",
"      ]. However, as noted above, most dialysis patients have a low serum bicarbonate; normal bicarbonate concentrations usually reflect reduced protein intake and malnutrition. After controlling their analysis for markers of poor nutrition, the authors found that patients who had a serum bicarbonate &lt;22",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      had a significantly greater mortality risk as compared with patients who had higher values.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11936209\">",
"    <span class=\"h2\">",
"     Association with progression of CKD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies in patients with non-dialysis dependent CKD have found that lower serum bicarbonate concentrations are associated with a higher risk of progressive renal function loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/45,46,50-53\">",
"     45,46,50-53",
"    </a>",
"    ]. The following examples illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 1094 patients with CKD participating in the African American Study of Kidney Disease (AASK) trial, renal event rates (defined as ESRD, a 50 percent decline in glomerular filtration rate [GFR], or a 25",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      decline in GFR from baseline) were approximately three times higher in patients whose serum bicarbonate was &lt;20 as compared with &gt;25",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/46\">",
"       46",
"      </a>",
"      ]. After controlling for other factors, a serum bicarbonate of 28 to 30",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      was associated with the lowest risk for renal events.",
"     </li>",
"     <li>",
"      Among 5422 patients followed in an urban medical clinic, those whose serum bicarbonate was &le;22 as compared with 25 to 26",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      had a significantly increased risk for progression of renal disease (defined as a 50 percent reduction in estimated GFR or reaching an estimated GFR less than 15",
"      <span class=\"nowrap\">",
"       mL/min/.73",
"      </span>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"      ; adjusted hazard ratio 1.54, 95% CI 1.13-2.09) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3156012\">",
"    <span class=\"h3\">",
"     Potential mechanisms for progression of CKD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reason for the association between metabolic acidosis and more rapid progression of CKD is not clear and may not be causal. If causal, however, it may be due at least in part to the adaptive response of surviving nephrons to the loss of their neighboring nephrons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/54-60\">",
"     54-60",
"    </a>",
"    ]. Metabolic acidosis promotes an adaptive increase in ammonium excreted per nephron, which is associated with activation of the complement system, the renin-angiotensin system, and with increased renal production of endothelin-1, all of which may produce tubulointerstitial inflammation and chronic damage to the kidney (",
"    <a class=\"graphic graphic_algorithm graphicRef86978 \" href=\"mobipreview.htm?28/30/29165\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Development of metabolic acidosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/19/26938?source=see_link\">",
"     \"Secondary factors and progression of chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35925?source=see_link\">",
"     \"Endothelin and the kidney\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endothelin-1 may play an important role in the nephrotoxicity associated with metabolic acidosis. In rats, for example, metabolic acidosis induced through either partial nephrectomy or dietary supplementation increases renal endothelin-1 and promotes progressive renal functional decline in the rat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/59,62\">",
"     59,62",
"    </a>",
"    ]. Both endothelin receptor antagonists and bicarbonate supplementation ameliorated the nephrotoxicity of the acidosis. However, the benefit was greater with bicarbonate supplementation, suggesting that other factors in addition to endothelin-1 contribute to the renal injury.",
"   </p>",
"   <p>",
"    Another potential mechanism involves activation of the renin-angiotensin system, which is important for urinary acidification but which can also result in proteinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/55\">",
"     55",
"    </a>",
"    ], renal damage, and progressive CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/55,62\">",
"     55,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT OF METABOLIC ACIDOSIS IN CKD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with acidemia are treated with bicarbonate therapy because acidemia impairs normal growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/63\">",
"     63",
"    </a>",
"    ]. Traditionally, however, exogenous alkali has not been used to treat the generally mild acidemia (arterial pH generally above 7.25) in asymptomatic adults with kidney disease. Reluctance to treat adults with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    may reflect concerns that the increased sodium intake will exacerbate the volume expansion and hypertension that are commonly present in chronic kidney disease (CKD), or that raising the pH can precipitate tetany in patients with hypocalcemia.",
"   </p>",
"   <p>",
"    However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    produces much less sodium retention and blood pressure elevation than comparable doses of sodium chloride [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/64\">",
"     64",
"    </a>",
"    ]. The factors responsible for this difference between bicarbonate and chloride are incompletely understood, although a similar phenomenon can be demonstrated in patients with salt-sensitive hypertension who have normal renal function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"     \"Salt intake, salt restriction, and essential hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5019243\">",
"    <span class=\"h2\">",
"     Therapeutic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;We broadly agree with 2013 Kidney Disease Improving Global Outcomes (KDIGO) guidelines that, in patients with CKD and metabolic acidosis, alkali therapy (usually with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    ) be used to maintain the serum bicarbonate concentration in the normal range (23 to 29",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. The upper bound of this target range is less clear than the lower bound, especially since the association between serum bicarbonate and mortality appears to be U-shaped [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11936141\">",
"     'Association with mortality'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Alkali therapy usually consists of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    or sodium citrate (citrate is rapidly metabolized to bicarbonate), typically in a dose of 0.5 to 1",
"    <span class=\"nowrap\">",
"     meq/kg",
"    </span>",
"    per day. Sodium citrate should be avoided in patients also taking aluminum-containing antacids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3156759\">",
"    <span class=\"h2\">",
"     Evidence supporting bicarbonate therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the adverse physiologic consequences linked to metabolic acidosis in CKD and the observational studies showing an association of metabolic acidosis with mortality and CKD progression, the rationale behind this approach is based upon randomized trials showing benefits of alkali therapy on:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progression of CKD",
"     </li>",
"     <li>",
"      Bone health",
"     </li>",
"     <li>",
"      Nutritional status",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Slowing of CKD progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bicarbonate supplementation appears to slow the progression of CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/68-71\">",
"     68-71",
"    </a>",
"    ]. The best data come from a single-center trial of 134 patients with stage 4 CKD (creatinine clearance, 15 to 30",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    ) and metabolic acidosis (baseline serum bicarbonate, 16 to 20",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    randomly assigned to oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    , beginning with a dose of 600 mg three times daily and increased as needed to achieve a serum bicarbonate &ge;23",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    or to no treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/68\">",
"     68",
"    </a>",
"    ]. At two years of follow-up, the following significant benefits of bicarbonate supplementation were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lower mean rate of decline of creatinine clearance compared with the control group (1.88 versus 5.93",
"      <span class=\"nowrap\">",
"       mL/min/1.73",
"      </span>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"      per year)",
"     </li>",
"     <li>",
"      A lower risk of having an annual decline in creatinine clearance of at least 3",
"      <span class=\"nowrap\">",
"       mL/min/1.73",
"      </span>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"      (9 versus 45 percent)",
"     </li>",
"     <li>",
"      A lower risk of end-stage renal disease (ESRD) (4 versus 22 patients [6.5 versus 33 percent])",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients in the bicarbonate group were more likely to develop edema and worsened hypertension requiring intensification of therapy, although this difference was not statistically significant. Other concerns about this trial include its open-label design, lack of a placebo control, and small number of events. In addition, the effect size (an 87 percent reduction in the relative risk for ESRD) is considerably larger than the true effects of most rigorously studied interventions. As an example, treating hypertensive patients with antihypertensive medications reduces the relative risk of cardiovascular events by only 20 to 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1\">",
"     1",
"    </a>",
"    ]. Provided that bicarbonate therapy does not substantially increase the rate of uncontrolled hypertension nor impair compliance with other therapies in patients with CKD, there seems to be little downside to its use while awaiting additional data to confirm the clinical benefit.",
"   </p>",
"   <p>",
"    A second trial randomly assigned 120 patients",
"    <strong>",
"     without",
"    </strong>",
"    metabolic acidosis who had mild CKD (mean estimated glomerular filtration rate [eGFR], 75",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    ) and an albumin-to-creatinine ratio &gt;300",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    , sodium chloride (each at 0.5",
"    <span class=\"nowrap\">",
"     meq/kg",
"    </span>",
"    per day), or to matching placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/69\">",
"     69",
"    </a>",
"    ]. At five years, the annual rate of decline in eGFR was slightly but significantly smaller in the sodium bicarbonate group (-1.5",
"    <span class=\"nowrap\">",
"     min/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    ) as compared with the sodium chloride and placebo groups (-2.0 and -2.1",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    , respectively). This study, which enrolled patients with early stage CKD, suggests that alkali therapy may help prevent the potentially harmful features associated with the kidney's adaptive response to a decreased number of functioning nephrons and therefore a decreased ability to excrete the daily acid load. (See",
"    <a class=\"local\" href=\"#H3156012\">",
"     'Potential mechanisms for progression of CKD'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Prevention of bone buffering",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone buffering of some of the excess hydrogen ions is associated with the release of calcium and phosphate from bone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/11,66,72\">",
"     11,66,72",
"    </a>",
"    ]. Hypocalciuria is one of the earliest findings in renal failure; therefore, calcium released from bone is probably lost in stool. Preventing this change may minimize the degree of negative calcium balance and prevent or delay the progression both of osteopenia and of hyperparathyroid bone disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/11,73-75\">",
"     11,73-75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/50/18218?source=see_link\">",
"     \"Pathogenesis of renal osteodystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A study of 21 patients on maintenance hemodialysis suggests that correction of metabolic acidosis improves metabolic bone disease. Patients were randomly assigned to therapy with a standard bath or a bicarbonate-supplemented bath [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/73\">",
"     73",
"    </a>",
"    ]. The predialysis plasma bicarbonate concentrations were 15.6 and 24",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    respectively. At 18 months, osteoid and osteoblastic surfaces and the plasma PTH level increased in the control group but were unchanged in patients in whom the acidosis was corrected. A similar benefit in terms of improved PTH control with bicarbonate therapy was observed in a randomized trial of patients with mild to moderate CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Correction of acidosis may act in part by diminishing the stimulus to hyperparathyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/32\">",
"     32",
"    </a>",
"    ]. This mechanism was suggested in a report of eight patients on maintenance hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/32\">",
"     32",
"    </a>",
"    ]. Enhanced therapy of acidosis with bicarbonate-supplemented dialysate (40",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    resulted in increased sensitivity of the parathyroid glands to ionized calcium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Improved nutritional status and lean body mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uremic acidosis can increase skeletal muscle breakdown and diminish albumin synthesis, leading to muscle wasting and muscle weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/76-80\">",
"     76-80",
"    </a>",
"    ]. The hypercatabolic state appears to be mediated by acidosis, acting in part by increased release of cortisol and diminished release of insulin-like growth factor-I (IGF-I) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/76-78,81\">",
"     76-78,81",
"    </a>",
"    ] and by inhibition of insulin signaling through phosphoinositide 3-kinase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/37\">",
"     37",
"    </a>",
"    ], leading to loss of lean body mass and muscle weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/76\">",
"     76",
"    </a>",
"    ]. The degree of muscle breakdown may be exacerbated by institution of a low-protein diet, which is occasionally used in an attempt to minimize progressive renal injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/45/2777?source=see_link\">",
"     \"Protein restriction and progression of chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These abnormalities in muscle function",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    albumin metabolism can be reversed by alkali therapy to correct the acidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/78\">",
"     78",
"    </a>",
"    ], including optimal correction of acidosis in patients undergoing chronic dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. In the previously cited randomized trial, bicarbonate significantly improved dietary protein intake and decreased protein catabolism in parallel with increased serum albumin and lean body mass in predialysis patients with CKD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alkali therapy may also be beneficial in children in whom acidemia can contribute to the impairment in growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/63,79\">",
"     63,79",
"    </a>",
"    ]. Experimental studies have identified a number of abnormalities in the growth hormone axis that are induced by metabolic acidosis and may contribute to the inhibition of growth. These include impaired pulsatile growth hormone secretion, decreased production and plasma levels of IGF-I due at least in part to an impaired hepatic response to circulating growth hormone, and reduced hepatic mRNA for the growth hormone receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/81,84-86\">",
"     81,84-86",
"    </a>",
"    ]. Improvement in growth hormone sensitivity has also been described in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/87\">",
"     87",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27881?source=see_link\">",
"     \"Growth hormone treatment in children with chronic kidney disease and postrenal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16810386\">",
"    <span class=\"h2\">",
"     Choice of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alkali therapy usually consists of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    or sodium citrate (citrate is rapidly metabolized to bicarbonate), typically in a dose of 0.5 to 1",
"    <span class=\"nowrap\">",
"     meq/kg",
"    </span>",
"    per day. We generally prefer citrate, which does not produce the bloating associated with bicarbonate therapy. However, sodium citrate should be avoided in patients also taking aluminum-containing antacids, as citrate markedly enhances intestinal aluminum absorption both by keeping aluminum soluble (via the formation of aluminum citrate) and by complexing with calcium in the intestinal lumen; the ensuing fall in the free calcium concentration can increase the permeability of the tight junctions of bowel epithelia, a change that can markedly enhance the passive absorption of aluminum (",
"    <a class=\"graphic graphic_figure graphicRef55777 \" href=\"mobipreview.htm?12/8/12429\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. As a result, patients taking aluminum-containing antacids to control hyperphosphatemia are at increased risk of developing aluminum intoxication if they are treated with sodium citrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. However, aluminum-based phosphate binders are seldom used.",
"   </p>",
"   <p>",
"    Metabolic acidosis can also be treated using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38628?source=see_link\">",
"     calcium citrate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/48/39685?source=see_link\">",
"     calcium acetate",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    . In addition, a small study of normokalemic patients with stage 4 CKD showed that dietary modification to increase consumption of fruits and vegetables (ie, an alkaline-ash diet) increased the serum bicarbonate above baseline levels, but to a lesser degree than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/91\">",
"     91",
"    </a>",
"    ]. However, because such diets are high in potassium, this approach to treating CKD patients with metabolic acidosis is associated with greater risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/92\">",
"     92",
"    </a>",
"    ]. The specific regimen should be individualized based upon patient tolerance, affordability, and individual comorbidities and biochemical characteristics.",
"   </p>",
"   <p>",
"    In patients on maintenance dialysis, an alternative method to correct the metabolic acidosis is to increase the bicarbonate concentration of the dialysate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/73,90\">",
"     73,90",
"    </a>",
"    ]. Levels as high as 42",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    may be required with hemodialysis to prevent predialysis acidosis. When implemented correctly, this regimen is generally well-tolerated and does not induce significant postdialysis alkalosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/93\">",
"     93",
"    </a>",
"    ]. However, it is possible that dialysate preparations containing higher amounts of bicarbonate equivalents (such as acetate or citrate) could induce significant metabolic alkalosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/24/41353/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acid-base balance is normally maintained by the renal excretion of the daily acid load; elimination of this acid load is achieved by the urinary excretion of hydrogen ions, both as titratable acidity and as ammonium. Near-normal balance can be maintained even if the acid load is modestly increased since acid excretion rises appropriately, primarily via increased ammonium production and excretion (",
"      <a class=\"graphic graphic_figure graphicRef60880 \" href=\"mobipreview.htm?7/22/7533\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Acid-base balance in chronic kidney disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As the number of functioning nephrons declines in chronic kidney disease (CKD), acid excretion is initially maintained by an increase in the ammonium excreted per nephron. However, total ammonium excretion begins to fall when the glomerular filtration rate (GFR) is below 40 to 50",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"      As a result, CKD leads to retention of hydrogen ions. The retained acid is buffered by bicarbonate in the extracellular fluid, by tissue buffers, and by bone. With worsening renal function, however, progressive metabolic acidosis can develop. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Development of metabolic acidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic metabolic acidosis in patients with CKD may produce a variety of pathophysiologic changes (see",
"      <a class=\"local\" href=\"#H117255428\">",
"       'Consequences of metabolic acidosis in CKD'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Bone resorption and osteopenia",
"     </li>",
"     <li>",
"      Aggravation of secondary hyperparathyroidism",
"     </li>",
"     <li>",
"      Reduced respiratory reserve and exhaustion of body buffer systems, resulting in increased severity of acute intercurrent illnesses",
"     </li>",
"     <li>",
"      Reduced Na",
"      <sup>",
"       +",
"      </sup>",
"      -K",
"      <sup>",
"       +",
"      </sup>",
"      -ATPase activity in red blood cells and myocardial cells, which could impair myocardial contractility and produce congestive heart failure",
"     </li>",
"     <li>",
"      Increased muscle protein catabolism",
"     </li>",
"     <li>",
"      Endocrine disorders such as resistance to growth hormone, insulin resistance, and hypertriglyceridemia",
"     </li>",
"     <li>",
"      Systemic inflammation",
"     </li>",
"     <li>",
"      Hypotension and malaise",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Observational studies in patients with non-dialysis dependent CKD and end-stage renal disease (ESRD) have described a significant association of metabolic acidosis with higher mortality. (See",
"      <a class=\"local\" href=\"#H11936141\">",
"       'Association with mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Observational studies in patients with non-dialysis dependent CKD have found that lower serum bicarbonate concentrations are associated with a higher risk of progressive renal function loss. The reason for this association is not clear, but several mechanisms have been proposed (",
"      <a class=\"graphic graphic_algorithm graphicRef86978 \" href=\"mobipreview.htm?28/30/29165\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11936209\">",
"       'Association with progression of CKD'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3156012\">",
"       'Potential mechanisms for progression of CKD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Our approach to therapy of metabolic acidosis in patients with CKD (described in the next bullet) is based upon randomized trials showing benefits of alkali therapy on (see",
"      <a class=\"local\" href=\"#H3156759\">",
"       'Evidence supporting bicarbonate therapy'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Progression of CKD (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Slowing of CKD progression'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Bone health (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Prevention of bone buffering'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Nutritional status (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Improved nutritional status and lean body mass'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with CKD who have metabolic acidosis, we suggest alkali therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We aim to maintain the serum bicarbonate concentration in the normal range (23 to 29",
"      <span class=\"nowrap\">",
"       meq/L).",
"      </span>",
"      Alkali therapy in such patients usually consists of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      or sodium citrate (citrate is rapidly metabolized to bicarbonate), typically in a daily dose of 0.5 to 1",
"      <span class=\"nowrap\">",
"       meq/kg",
"      </span>",
"      per day. Sodium citrate should be avoided in patients also taking aluminum-containing antacids. In patients on maintenance dialysis, an alternative method to correct the metabolic acidosis is to increase the bicarbonate concentration in the dialysate. (See",
"      <a class=\"local\" href=\"#H5019243\">",
"       'Therapeutic approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16810386\">",
"       'Choice of therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/1\">",
"      Warnock DG. Uremic acidosis. Kidney Int 1988; 34:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/2\">",
"      Bailey JL. Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease. Kidney Int Suppl 2005; :S15.",
"     </a>",
"    </li>",
"    <li>",
"     Moe OW, Rector FC, Alpern RJ. Renal regulation of acid-base metabolism. In: Maxwell and Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism, 5th ed, Narins RG.  (Ed), McGraw-Hill, Inc., New York 1994. p.203.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/4\">",
"      Garibotto G, Sofia A, Robaudo C, et al. Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis. J Am Soc Nephrol 2004; 15:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/5\">",
"      GOODMAN AD, LEMANN J Jr, LENNON EJ, RELMAN AS. PRODUCTION, EXCRETION, AND NET BALANCE OF FIXED ACID IN PATIENTS WITH RENAL ACIDOSIS. J Clin Invest 1965; 44:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/6\">",
"      Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 2005; 45:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/7\">",
"      Kopple JD, Kalantar-Zadeh K, Mehrotra R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int Suppl 2005; :S21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/8\">",
"      Widmer B, Gerhardt RE, Harrington JT, Cohen JJ. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med 1979; 139:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/9\">",
"      Welbourne T, Weber M, Bank N. The effect of glutamine administration on urinary ammonium excretion in normal subjects and patients with renal disease. J Clin Invest 1972; 51:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/10\">",
"      Uribarri J, Douyon H, Oh MS. A re-evaluation of the urinary parameters of acid production and excretion in patients with chronic renal acidosis. Kidney Int 1995; 47:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/11\">",
"      Lemann J Jr, Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 1966; 45:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/12\">",
"      Eustace JA, Astor B, Muntner PM, et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004; 65:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/13\">",
"      Kovesdy CP. Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Nephrol Dial Transplant 2012; 27:3056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/14\">",
"      Wallia R, Greenberg A, Piraino B, et al. Serum electrolyte patterns in end-stage renal disease. Am J Kidney Dis 1986; 8:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/15\">",
"      Hakim RM, Lazarus JM. Biochemical parameters in chronic renal failure. Am J Kidney Dis 1988; 11:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/16\">",
"      Kurtz I, Maher T, Hulter HN, et al. Effect of diet on plasma acid-base composition in normal humans. Kidney Int 1983; 24:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/17\">",
"      Uribarri J, Levin NW, Delmez J, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis 1999; 34:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/18\">",
"      Kirschbaum B. Spurious metabolic acidosis in hemodialysis patients. Am J Kidney Dis 2000; 35:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/19\">",
"      Caravaca F, Arrobas M, Pizarro JL, Esp&aacute;rrago JF. Metabolic acidosis in advanced renal failure: differences between diabetic and nondiabetic patients. Am J Kidney Dis 1999; 33:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/20\">",
"      Amb&uuml;hl PM. Posttransplant metabolic acidosis: a neglected factor in renal transplantation? Curr Opin Nephrol Hypertens 2007; 16:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/21\">",
"      Better OS, Chaimowitz C, Alroy GG, Sisman I. Spontaneous remission of the defect in urinary acidification after cadaver kidney homotransplantation. Lancet 1970; 1:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/22\">",
"      Yakupoglu HY, Corsenca A, Wahl P, et al. Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation 2007; 84:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/23\">",
"      Massry SG, Preuss HG, Maher JF, Schreiner GE. Renal tubular acidosis after cadaver kidney homotransplantation. Studies on mechanism. Am J Med 1967; 42:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/24\">",
"      Better OS, Chaimowitz C, Naveh Y, et al. Syndrome of incomplete renal tubular acidosis after cadaver kidney transplantation. Ann Intern Med 1969; 71:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/25\">",
"      Gy&ouml;ry AZ, Stewart JH, George CR, et al. Renal tubular acidosis, acidosis due to hyperkalaemia, hypercalcaemia, disordered citrate metabolism and other tubular dysfunctions following human renal transplantation. Q J Med 1969; 38:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/26\">",
"      Schwarz C, Benesch T, Kodras K, et al. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant 2006; 21:2615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/27\">",
"      Better OS. Tubular dysfunction following kidney transplantation. Nephron 1980; 25:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/28\">",
"      Green J, Kleeman CR. Role of bone in regulation of systemic acid-base balance. Kidney Int 1991; 39:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/29\">",
"      Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 2004; 13:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/30\">",
"      Bushinsky DA, Ori Y. Effects of metabolic and respiratory acidosis on bone. Curr Opin Nephrol Hypertens 1993; 2:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/31\">",
"      Greenberg AJ, McNamara H, McCrory WW. Metabolic balance studies in primary renal tubular acidosis: effects of acidosis on external calcium and phosphorus balances. J Pediatr 1966; 69:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/32\">",
"      Graham KA, Hoenich NA, Tarbit M, et al. Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 1997; 8:627.",
"     </a>",
"    </li>",
"    <li>",
"     Tuso PJ, Nissenson AR, Danovitch GM. Electrolyte disorders in chronic renal failure. In: Maxwell and Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism, 5th ed, Narins RG.  (Ed), McGraw-Hill, Inc., New York City 1994. p.1195.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/34\">",
"      Levin ML, Rector FC Jr, Seldin DW. The effects of chronic hypokalaemia, hyponatraemia, and acid-base alterations on erythrocyte sodium transport. Clin Sci 1972; 43:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/35\">",
"      Brown RH Jr, Cohen I, Noble D. The interactions of protons, calcium and potassium ions on cardiac Purkinje fibres. J Physiol 1978; 282:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/36\">",
"      Mitchell JH, Wildenthal K, Johnson RL Jr. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1972; 1:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/37\">",
"      Franch HA, Raissi S, Wang X, et al. Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis. Am J Physiol Renal Physiol 2004; 287:F700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/38\">",
"      Mitch WE. Influence of metabolic acidosis on nutrition. Am J Kidney Dis 1997; 29:xlvi.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/39\">",
"      Franch HA, Mitch WE. Catabolism in uremia: the impact of metabolic acidosis. J Am Soc Nephrol 1998; 9:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/40\">",
"      Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 1997; 8:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/41\">",
"      May RC, Masud T, Logue B, et al. Metabolic acidosis accelerates whole body protein degradation and leucine oxidation by a glucocorticoid-dependent mechanism. Miner Electrolyte Metab 1992; 18:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/42\">",
"      Ord&oacute;&ntilde;ez FA, Santos F, Mart&iacute;nez V, et al. Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatr Nephrol 2000; 14:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/43\">",
"      Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 2004; 17:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/44\">",
"      Bellocq A, Suberville S, Philippe C, et al. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. J Biol Chem 1998; 273:5086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/45\">",
"      Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant 2009; 24:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/46\">",
"      Raphael KL, Wei G, Baird BC, et al. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int 2011; 79:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/47\">",
"      Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/48\">",
"      Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/49\">",
"      Wu DY, Shinaberger CS, Regidor DL, et al. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol 2006; 1:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/50\">",
"      Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis 2009; 54:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/51\">",
"      de Brito-Ashurst I, Varagunam M, Raftery MJ, et al. The effect of metabolic acidosis on the rate of decline of glomerular filtration rate in patients with stage 4 chronic kidney disease. Nephrology 2005; 10 (Suppl):A248 (abstr).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/52\">",
"      Kovesdy CP, Kalantar-Zadeh K. Oral bicarbonate: renoprotective in CKD? Nat Rev Nephrol 2010; 6:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/53\">",
"      Menon V, Tighiouart H, Vaughn NS, et al. Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis 2010; 56:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/54\">",
"      Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/55\">",
"      Ng HY, Chen HC, Tsai YC, et al. Activation of intrarenal renin-angiotensin system during metabolic acidosis. Am J Nephrol 2011; 34:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/56\">",
"      Halperin ML, Ethier JH, Kamel KS. Ammonium excretion in chronic metabolic acidosis: benefits and risks. Am J Kidney Dis 1989; 14:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/57\">",
"      Torres VE, Mujwid DK, Wilson DM, Holley KH. Renal cystic disease and ammoniagenesis in Han:SPRD rats. J Am Soc Nephrol 1994; 5:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/58\">",
"      Wesson DE. Regulation of kidney acid excretion by endothelins. Kidney Int 2006; 70:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/59\">",
"      Wesson DE, Nathan T, Rose T, et al. Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int 2007; 71:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/60\">",
"      Wesson DE, Simoni J. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Kidney Int 2009; 75:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/61\">",
"      Frassetto LA, Hsu CY. Metabolic acidosis and progression of chronic kidney disease. J Am Soc Nephrol 2009; 20:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/62\">",
"      Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int 2010; 78:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/63\">",
"      McSherry E, Morris RC Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 1978; 61:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/64\">",
"      Husted FC, Nolph KD, Maher JF. NaHCO3 and NaC1 tolerance in chronic renal failure. J Clin Invest 1975; 56:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/65\">",
"      KDIGO. Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl 2013; 3:73. file://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/66\">",
"      Alpern RJ, Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 1997; 29:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/67\">",
"      Mitch WE. Dietary protein restriction in patients with chronic renal failure. Kidney Int 1991; 40:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/68\">",
"      de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009; 20:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/69\">",
"      Mahajan A, Simoni J, Sheather SJ, et al. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 2010; 78:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/70\">",
"      Phisitkul S, Khanna A, Simoni J, et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 2010; 77:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/71\">",
"      Rustom R, Grime JS, Costigan M, et al. Oral sodium bicarbonate reduces proximal renal tubular peptide catabolism, ammoniogenesis, and tubular damage in renal patients. Ren Fail 1998; 20:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/72\">",
"      Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47:1816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/73\">",
"      Lefebvre A, de Vernejoul MC, Gueris J, et al. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989; 36:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/74\">",
"      Mathur RP, Dash SC, Gupta N, et al. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail 2006; 28:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/75\">",
"      Starke A, Corsenca A, Kohler T, et al. Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality. Clin J Am Soc Nephrol 2012; 7:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/76\">",
"      Williams B, Hattersley J, Layward E, Walls J. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 1991; 40:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/77\">",
"      Garibotto G, Russo R, Sofia A, et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994; 45:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/78\">",
"      Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996; 97:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/79\">",
"      Boirie Y, Broyer M, Gagnadoux MF, et al. Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int 2000; 58:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/80\">",
"      L&ouml;fberg E, Gutierrez A, Anderstam B, et al. Effect of bicarbonate on muscle protein in patients receiving hemodialysis. Am J Kidney Dis 2006; 48:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/81\">",
"      Ballmer PE, McNurlan MA, Hulter HN, et al. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995; 95:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/82\">",
"      Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 1996; 49:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/83\">",
"      Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 1998; 13:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/84\">",
"      Challa A, Krieg RJ Jr, Thabet MA, et al. Metabolic acidosis inhibits growth hormone secretion in rats: mechanism of growth retardation. Am J Physiol 1993; 265:E547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/85\">",
"      Challa A, Chan W, Krieg RJ Jr, et al. Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor. Kidney Int 1993; 44:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/86\">",
"      Br&uuml;ngger M, Hulter HN, Krapf R. Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int 1997; 51:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/87\">",
"      Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 2004; 19:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/88\">",
"      Molitoris BA, Froment DH, Mackenzie TA, et al. Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int 1989; 36:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/89\">",
"      Nolan CR, Califano JR, Butzin CA. Influence of calcium acetate or calcium citrate on intestinal aluminum absorption. Kidney Int 1990; 38:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/90\">",
"      Walker JA, Sherman RA, Cody RP. The effect of oral bases on enteral aluminum absorption. Arch Intern Med 1990; 150:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/91\">",
"      Goraya N, Simoni J, Jo CH, Wesson DE. A Comparison of Treating Metabolic Acidosis in CKD Stage 4 Hypertensive Kidney Disease with Fruits and Vegetables or Sodium Bicarbonate. Clin J Am Soc Nephrol 2013; 8:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/92\">",
"      Yaqoob MM. Treatment of Acidosis in CKD. Clin J Am Soc Nephrol 2013; 8:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/24/41353/abstract/93\">",
"      Oettinger CW, Oliver JC. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. J Am Soc Nephrol 1993; 3:1804.",
"     </a>",
"    </li>",
"    <li>",
"     Dialysate Concentrates Used in Hemodialysis: Safety Communication - Alkali Dosing Errors. file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305630.htm (Accessed on February 08, 2013).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2293 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-220.255.2.145-1001A7F1F4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41353=[""].join("\n");
var outline_f40_24_41353=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3156775\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      ACID-BASE BALANCE IN CHRONIC KIDNEY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Development of metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H117255428\">",
"      CONSEQUENCES OF METABOLIC ACIDOSIS IN CKD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11936141\">",
"      Association with mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11936209\">",
"      Association with progression of CKD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3156012\">",
"      - Potential mechanisms for progression of CKD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT OF METABOLIC ACIDOSIS IN CKD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5019243\">",
"      Therapeutic approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3156759\">",
"      Evidence supporting bicarbonate therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Slowing of CKD progression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Prevention of bone buffering",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Improved nutritional status and lean body mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16810386\">",
"      Choice of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2293\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2293|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?28/30/29165\" title=\"algorithm 1\">",
"      Metabolic acidosis mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2293|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/22/7533\" title=\"figure 1\">",
"      Low NH4 excretion in CRF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/8/12429\" title=\"figure 2\">",
"      Citrate and aluminum absorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2293|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/47/14076\" title=\"table 1\">",
"      Revised CKD classification based upon GFR and albuminuria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31432?source=related_link\">",
"      Approach to the adult with metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6330?source=related_link\">",
"      Approach to the child with metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=related_link\">",
"      Clinical manifestations of hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35925?source=related_link\">",
"      Endothelin and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27881?source=related_link\">",
"      Growth hormone treatment in children with chronic kidney disease and postrenal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/32/10759?source=related_link\">",
"      Overview of renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/50/18218?source=related_link\">",
"      Pathogenesis of renal osteodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/18/25891?source=related_link\">",
"      Potassium balance in acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/45/2777?source=related_link\">",
"      Protein restriction and progression of chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=related_link\">",
"      Salt intake, salt restriction, and essential hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/19/26938?source=related_link\">",
"      Secondary factors and progression of chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/41/27288?source=related_link\">",
"      Simple and mixed acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21526?source=related_link\">",
"      The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_24_41354="Acute liver TPL rejection I";
var content_f40_24_41354=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80063%7EGAST%2F60368%7EGAST%2F79840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80063%7EGAST%2F60368%7EGAST%2F79840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute cellular hepatic allograft rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power light micrograph of a liver biopsy from a patient with acute cellular hepatic allograft rejection shows an expanded portal triad containing mixed inflammatory cells. These is also evidence of ductulitis and endotheliitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Jensen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute hepatic allograft rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a liver transplant biopsy shows dense lymphocytic infiltrate (cellular rejection) and endotheliitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endotheliitis in acute hepatic allograft rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a liver biopsy from a liver transplant shows endotheliitis involving a central hepatic vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Jensen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41354=[""].join("\n");
var outline_f40_24_41354=null;
var title_f40_24_41355="Drugs causing erythroderma";
var content_f40_24_41355=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F88412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F88412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs most frequently reported as cause of erythroderma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        ACE inhibitors (enalapril, lisinopril)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allopurinol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bevacizumab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chlorpromazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dapsone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythropoietin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gold salts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydroxychloroquine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Imatinib",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isoniazid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenobarbital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Piroxicam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proton pump inhibitors (omeprazole, esomeprazole, pantoprazole)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retinoids (acitretin, isotretinoin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Streptomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfasalazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terbinafine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thalidomide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim/sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Grant-Kels JM, Fedeles F, Rothe MJ. Exfoliative dermatitis. In: Fitzpatrick's Dermatology in General Medicine, 8th ed, Goldsmith L, Katz S, Gilchrest B, et al (Eds), McGraw-Hill, 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41355=[""].join("\n");
var outline_f40_24_41355=null;
var title_f40_24_41356="Nonprogressive versus progressive precocious puberty";
var content_f40_24_41356=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical characteristics of nonprogressive versus progressive precocious puberty",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nonprogressive precocious puberty",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gonadotropin-dependent",
"        <br/>",
"        (central)",
"        <br/>",
"        precocious puberty",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gonadotropin-independent",
"        <br/>",
"        (peripheral)",
"        <br/>",
"        precocious puberty",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physical examination: Advancement through pubertal stages (Tanner stage)",
"       </td>",
"       <td>",
"        No progression in Tanner staging during 3 to 6 months of observation",
"       </td>",
"       <td>",
"        Progression to next pubertal stage in 3 to 6 months",
"       </td>",
"       <td>",
"        Progression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth velocity",
"       </td>",
"       <td>",
"        Normal for bone age and relationship to peak height velocity",
"       </td>",
"       <td>",
"        Accelerated (&gt;6 cm per year)*",
"       </td>",
"       <td>",
"        Accelerated*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone age",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Advanced for height age",
"       </td>",
"       <td>",
"        Advanced for height age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum estradiol concentration (girls)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Undetectable",
"       </td>",
"       <td>",
"        Measurable, variable, and increasing",
"       </td>",
"       <td>",
"        Measureable, variable, and increasing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum testosterone concentration (boys, or girls with virilization)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Prepubertal",
"       </td>",
"       <td>",
"        Pubertal and increasing",
"       </td>",
"       <td>",
"        Pubertal and increasing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basal (unstimulated) serum LH concentration",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Normal (prepubertal)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Normal or elevated (as compared to prepubertal levels)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Suppressed or normal (prepubertal)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GnRH (or GnRHa) stimulation test",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        LH peak in the prepubertal range",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        LH peak elevated (in the pubertal range)",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        No change from baseline, or LH peak in the prepubertal range",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * UNLESS the patient has already passed his or her peak height velocity at the time of evaluation, in which case growth velocity may be normal or decreased for chronological age.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Serum concentrations of gonadal steroids and LH should be measured using ultrasensitive assays with detection limits adapted to the pediatric age group (ie, LH detection limits near 0.1 mIU/mL).",
"      <br>",
"       &Delta; In most laboratories, basal prepubertal concentrations of LH are below 0.1 mIU/mL.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        In most laboratories, the upper limit of normal for LH after GnRH stimulation is 3.3 to 5.0 mIU/mL.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41356=[""].join("\n");
var outline_f40_24_41356=null;
var title_f40_24_41357="Contents: Pulmonology calculators";
var content_f40_24_41357=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pulmonology calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pulmonology calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical Criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/8/3205\">",
"           Calculator: APACHE II scoring system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/50/23329\">",
"           Calculator: BODE Index for COPD survival prediction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/29/17874\">",
"           Calculator: Epworth Sleepiness Scale (ESS)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/35/40496\">",
"           Calculator: Pulmonary embolism Wells score",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/51/31539\">",
"           Calculator: A-a gradient (alveolar-arterial gradient; AaG)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/31/24049\">",
"           Calculator: Diffusing capacity for carbon monoxide (DLCO) corrected for anemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/10/14497\">",
"           Calculator: Epoprostenol (Flolan) Infusion Rate Calculator",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/47/22257\">",
"           Calculator: In-Flight PaO2 Estimation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/13/12497\">",
"           Calculator: In-Flight PaO2 Estimation (using PFT's)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34928\">",
"           Calculator: Nasal Canula Oxygen Fractional Inspired O2 (FIO2) Estimate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/49/14098\">",
"           Calculator: Oxygenation index",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/9/14481\">",
"           Calculator: Peak Expiratory Flow Prediction",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-634DD432E6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_24_41357=[""].join("\n");
var outline_f40_24_41357=null;
var title_f40_24_41358="Guideline c-spine clearance unreliable child";
var content_f40_24_41358=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Guideline for clearing the cervical spine in the unreliable pediatric patient",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 362px; height: 550px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     c-spine: cervical spine; MRI: magnetic resonance imaging; CT: computed tomography; LOC: level of consciousness.",
"     <br>",
"      * Unconscious or decreased level of consciousness with Glasgow coma scale &lt;15.",
"      <br>",
"       &Delta; Change to long-term cervical spine collar as soon as appropriate.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Consider thoracolumbar spine injury in those with a documented cervical spine injury.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Chung S, Mikrogianakis A, Wales PW, et al. Trauma Association of Canada Pediatric Subcommittee National Pediatric Cervical Spine Evaluation Pathway: Consensus Guidelines. J Trauma 2011; 70:873. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41358=[""].join("\n");
var outline_f40_24_41358=null;
var title_f40_24_41359="Primary tracheal tum ENDO";
var content_f40_24_41359=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    51-year-old female with primary tracheal adenoid cystic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bronchoscopic image of a primary tracheal adenoid cystic carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James R Jett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_24_41359=[""].join("\n");
var outline_f40_24_41359=null;
